Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2016);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;12.597;Q1;348;257;625;8837;7341;261;11.57;34.39;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
2;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;8.284;Q1;210;31;87;3850;1372;85;13.35;124.19;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
3;21191;Pharmacological Reviews;journal;15210081, 00316997;8.051;Q1;241;26;94;10565;1971;94;20.41;406.35;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
4;4700152457;Nano Today;journal;17480132;6.225;Q1;155;52;194;6229;2126;130;11.34;119.79;Netherlands;Western Europe;Elsevier;1970, 2006-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;5.35;Q1;225;97;267;8367;2838;211;11;86.26;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
6;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;4.45;Q1;211;131;331;24955;3995;330;11.58;190.5;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;4.262;Q1;331;197;479;31881;7269;432;11.44;161.83;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
8;12611;Drug Resistance Updates;journal;13687646, 15322084;3.794;Q1;119;31;41;5374;453;41;12.1;173.35;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
9;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;3.747;Q1;227;323;907;18423;5819;860;5.94;57.04;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
10;26371;Natural Product Reports;journal;02650568, 14604752;3.534;Q1;188;77;233;10320;2404;227;10.04;134.03;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
11;12455;Molecular Therapy;journal;15250024, 15250016;3.362;Q1;185;237;704;10532;4381;582;5.66;44.44;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
12;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.259;Q1;233;305;919;38436;5646;909;6.19;126.02;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
13;21100456838;Cell Chemical Biology;journal;24519448, 24519456;3.258;Q1;190;187;540;8036;3149;526;6.04;42.97;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;18148;Pain;journal;18726623, 03043959;3.009;Q1;269;367;1123;18151;5859;879;4.56;49.46;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
15;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;2.844;Q1;66;11;19;1872;114;13;4.64;170.18;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
16;21100218543;Molecular Therapy - Nucleic Acids;journal;21622531;2.795;Q1;71;115;207;5042;1352;202;6.95;43.84;United States;Northern America;Cell Press;2012-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
17;4400151524;Particle and Fibre Toxicology;journal;17438977;2.755;Q1;105;67;171;4492;1732;166;9.04;67.04;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
18;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.701;Q1;134;33;111;6234;1030;111;9.22;188.91;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
19;20084;British Journal of Pharmacology;journal;14765381, 00071188;2.67;Q1;223;257;1303;17373;7060;1277;5.49;67.6;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
20;21100466864;Journal for ImmunoTherapy of Cancer;journal;20511426;2.668;Q1;80;90;146;3979;761;138;5.14;44.21;United Kingdom;Western Europe;BMJ Publishing Group;2013-2021;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1)"
21;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;2.552;Q1;139;104;364;6079;2084;334;5.67;58.45;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
22;23010;Journal of Controlled Release;journal;18734995, 01683659;2.463;Q1;282;527;1439;35222;11755;1353;7.94;66.83;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
23;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.456;Q1;276;756;2244;45480;14239;2229;6.45;60.16;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
24;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;2.456;Q1;143;871;2214;41944;10182;2190;4.34;48.16;United States;Northern America;Public Library of Science;2007-2021;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
25;19700174891;Perspectives in Medicinal Chemistry;journal;11773910, 1177391X;2.425;Q1;16;2;8;277;83;8;10.38;138.5;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2011, 2014-2016;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
26;21100232818;Emerging Microbes and Infections;journal;22221751;2.394;Q1;68;87;133;3185;652;113;4.76;36.61;United Kingdom;Western Europe;Nature Publishing Group;2012-2021;"Drug Discovery (Q1); Epidemiology (Q1); Immunology (Q1); Infectious Diseases (Q1); Medicine (miscellaneous) (Q1); Microbiology (Q1); Parasitology (Q1); Virology (Q1)"
27;21100207003;Theranostics;journal;18387640;2.375;Q1;115;188;300;10661;2921;290;9.9;56.71;Australia;Pacific Region;Ivyspring International Publisher;2012-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
28;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;2.366;Q1;195;175;586;5650;3351;530;5.36;32.29;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
29;20435;Neuropharmacology;journal;00283908, 18737064;2.355;Q1;176;434;1229;30588;6283;1206;5.19;70.48;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Cellular and Molecular Neuroscience (Q1); Pharmacology (Q1)"
30;24749;Addiction Biology;journal;13556215, 13691600;2.296;Q1;83;100;296;5735;1325;294;4.14;57.35;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
31;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.283;Q1;203;578;1600;17609;7277;1370;4.57;30.47;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
32;5100155080;Neurotherapeutics;journal;19337213;2.283;Q1;122;80;225;7887;1267;211;5.63;98.59;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
33;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.275;Q1;269;1038;3159;36780;14473;2979;4.34;35.43;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
34;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.207;Q1;146;122;378;6885;1884;354;4.35;56.43;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
35;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.199;Q1;202;136;561;8804;2430;561;4.19;64.74;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
36;21196;Drug Discovery Today;journal;18785832, 13596446;2.17;Q1;185;209;586;15377;3835;544;6.39;73.57;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
37;19700176055;F1000 Biology Reports;journal;1757594X, 17404118;2.122;Q1;31;0;2;0;14;2;0;0;United Kingdom;Western Europe;Faculty of 1000 Ltd;2010-2013;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Immunology and Microbiology (miscellaneous)  (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
38;110112;Journal of Immunotherapy;journal;15249557, 15374513;2.11;Q1;97;44;149;1983;692;145;4.17;45.07;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1)"
39;23109;Journal of Psychopharmacology;journal;14617285, 02698811;2.095;Q1;121;140;391;8640;1776;372;4.59;61.71;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
40;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;2.085;Q1;118;192;622;10425;2899;605;4.49;54.3;Netherlands;Western Europe;Elsevier;1990-2021;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)"
41;26380;Drug and Alcohol Dependence;journal;03768716;2.064;Q1;173;417;1266;19342;4824;1252;3.44;46.38;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
42;19617;Antiviral Research;journal;01663542, 18729096;2.053;Q1;134;206;635;8977;3058;607;4.65;43.58;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q1)"
43;21169;Pharmacological Research;journal;10436618, 10961186;2.037;Q1;147;406;440;32415;2425;424;4.93;79.84;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q1)
44;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.997;Q1;113;118;600;6544;2660;589;4.34;55.46;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
45;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.987;Q1;89;19;41;1932;274;41;6.22;101.68;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
46;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.929;Q1;134;175;558;16223;2626;551;4.46;92.7;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
47;21100225611;Advanced healthcare materials;journal;21922640, 21922659;1.927;Q1;105;320;673;17191;3826;650;5.39;53.72;United Kingdom;Western Europe;John Wiley and Sons Ltd;2012-2021;"Biomaterials (Q1); Biomedical Engineering (Q1); Pharmaceutical Science (Q1)"
48;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.902;Q1;206;232;963;14397;4797;845;4.78;62.06;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
49;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;1.836;Q1;40;39;86;2201;438;86;5.4;56.44;Netherlands;Western Europe;Elsevier BV;2011-2021;"Infectious Diseases (Q1); Parasitology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
50;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.834;Q1;233;244;712;11971;3105;709;4.21;49.06;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
51;23916;Environmental Pollution;journal;02697491, 18736424;1.827;Q1;249;945;1435;51441;8111;1398;5.33;54.43;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
52;21100777378;Therapeutic Advances in Vaccines;journal;20510136;1.81;Q1;5;0;6;0;62;6;10.33;0;United Kingdom;Western Europe;;;"Drug Discovery (Q1); Immunology and Allergy (Q1); Oncology (Q1); Pharmacology (medical) (Q1); Immunology (Q2)"
53;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.809;Q1;117;44;127;4733;707;118;5.46;107.57;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
54;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.802;Q1;177;327;739;14596;3607;732;4.96;44.64;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
55;21165;PharmacoEconomics;journal;11707690, 11792027;1.797;Q1;104;112;310;4712;991;258;3.44;42.07;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
56;19600166320;Protein and Cell;journal;16748018, 1674800X;1.79;Q1;74;99;320;3851;1165;280;3.98;38.9;China;Asiatic Region;Higher Education Press;2010-2021;"Biochemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Cell Biology (Q2)"
57;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.774;Q1;77;66;229;3958;957;222;3.37;59.97;United States;Northern America;Springer New York;2006-2021;"Immunology and Allergy (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1); Immunology (Q2)"
58;145164;Human Genomics;journal;14739542, 14797364;1.77;Q1;59;37;76;1003;260;74;3.35;27.11;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q1); Genetics (Q1); Molecular Medicine (Q1); Molecular Biology (Q2)"
59;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;1.765;Q1;94;119;377;12656;1700;366;4.52;106.35;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
60;24604;Archives of Toxicology;journal;14320738, 03405761;1.758;Q1;121;228;565;15263;2864;467;4.69;66.94;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
61;21100214102;Frontiers in Pharmacology;journal;16639812;1.729;Q1;104;516;725;33431;3080;671;4.34;64.79;Switzerland;Western Europe;Frontiers Media S.A.;2010-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
62;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;1.714;Q1;36;6;17;656;72;0;5.27;109.33;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
63;21782;Psychopharmacology;journal;00333158, 14322072;1.714;Q1;202;349;1218;21019;4359;1172;3.43;60.23;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
64;4000148203;Handbook of Experimental Pharmacology;journal;01712004;1.71;Q1;96;54;350;5252;1434;318;4.13;97.26;Germany;Western Europe;Springer Heidelberg;2004-2021;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
65;4700152903;Forensic Toxicology;journal;18608965, 18608973;1.687;Q1;39;40;135;1429;490;120;3.8;35.73;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
66;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.687;Q1;133;210;523;11807;3498;509;6.48;56.22;United States;Northern America;Elsevier Inc.;2005-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
67;25218;Toxicological Sciences;journal;10960929, 10966080;1.629;Q1;193;237;797;11380;3544;758;4.21;48.02;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
68;144771;Clinical Trials;journal;17407753, 17407745;1.623;Q1;67;96;290;1871;527;238;1.92;19.49;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
69;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.599;Q1;169;110;269;6748;1357;244;4.64;61.35;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
70;5400152706;Nanotoxicology;journal;17435390, 17435404;1.596;Q1;94;146;295;8051;1825;288;6.04;55.14;United Kingdom;Western Europe;Informa Healthcare;2007-2021;"Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Toxicology (Q1)"
71;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;1.586;Q1;50;45;169;2511;743;166;4.38;55.8;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Internal Medicine (Q1); Pharmacology (Q1)"
72;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.567;Q1;75;128;425;6031;1509;324;3.34;47.12;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Physiology (medical) (Q2)"
73;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.565;Q1;159;291;950;14342;2943;919;2.81;49.29;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
74;17700156714;Pharmaceuticals;journal;14248247;1.553;Q1;69;77;172;6189;892;165;4.59;80.38;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
75;19700175015;Infection and Drug Resistance;journal;11786973;1.551;Q1;44;33;101;1683;446;101;4.86;51;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
76;24763;Addictive Behaviors;journal;03064603;1.548;Q1;135;256;868;10607;2873;861;3.32;41.43;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
77;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.543;Q1;153;297;820;12341;3105;713;3.41;41.55;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
78;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.538;Q1;138;405;1307;19086;6608;1293;4.91;47.13;United States;Northern America;American Chemical Society;2004-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
79;19427;Advances in Pharmacology;journal;15578925, 10543589;1.526;Q1;78;39;119;5476;454;0;3.7;140.41;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
80;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.521;Q1;115;111;406;5963;1657;401;4.01;53.72;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cancer Research (Q2); Cell Biology (Q2)"
81;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.498;Q1;129;132;341;4841;956;325;2.61;36.67;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
82;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.496;Q1;175;282;956;15536;4280;953;4.1;55.09;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
83;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;1.493;Q1;43;17;58;356;214;55;3.16;20.94;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q2)"
84;84948;Expert Opinion on Drug Delivery;journal;17425247;1.488;Q1;116;147;406;11820;2399;397;5.65;80.41;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science (Q1)
85;20783;Expert Review of Vaccines;journal;14760584, 17448395;1.482;Q1;91;141;416;11331;1357;386;3.28;80.36;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q1); Pharmacology (Q1); Immunology (Q2); Molecular Medicine (Q2)"
86;20700195026;Acta Pharmaceutica Sinica B;journal;22113843, 22113835;1.479;Q1;65;76;82;3746;416;73;5.07;49.29;Netherlands;Western Europe;Elsevier BV;2012, 2014-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
87;25219;Toxicology;journal;0300483X, 18793185;1.468;Q1;165;158;526;8293;2207;514;3.87;52.49;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
88;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.466;Q1;182;217;713;9295;2934;706;4.24;42.83;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
89;21100335701;Vaccines;journal;2076393X;1.457;Q1;50;48;95;4565;385;92;4.08;95.1;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2013-2021;"Drug Discovery (Q1); Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Immunology (Q2)"
90;21237;Drug Safety;journal;01145916, 11791942;1.454;Q1;131;105;313;5877;1111;270;3.45;55.97;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
91;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;1.442;Q1;56;47;86;2043;394;82;4.87;43.47;United Kingdom;Western Europe;SAGE Publications Ltd;2008-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Neurology (Q2)"
92;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1.412;Q1;73;216;677;5223;2609;669;3.81;24.18;United States;Northern America;American Chemical Society;2010-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
93;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.411;Q1;168;251;846;11318;4044;833;4.61;45.09;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
94;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;1.395;Q1;53;54;241;2113;703;236;2.44;39.13;United States;Northern America;Springer New York;2008-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmaceutical Science (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2)"
95;14990;Current Neuropharmacology;journal;18756190, 1570159X;1.385;Q1;82;120;169;12931;717;150;3.15;107.76;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous) (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2)"
96;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.377;Q1;90;77;227;3909;955;227;3.84;50.77;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
97;25096;Food and Chemical Toxicology;journal;18736351, 02786915;1.351;Q1;183;324;1577;18222;6671;1494;4;56.24;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
98;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;1.347;Q1;79;113;384;3588;1028;381;2.53;31.75;United States;Northern America;SAGE Publications Inc.;1996-2017;"Analytical Chemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Pharmacology (Q1); Biochemistry (Q2); Molecular Medicine (Q2)"
99;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.341;Q1;76;46;149;2674;452;142;2.67;58.13;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Pharmacology (Q1); Biochemistry (Q2); Cell Biology (Q2); Physiology (Q2)"
100;22477;Investigational New Drugs;journal;01676997, 15730646;1.34;Q1;90;89;457;2942;1595;455;3.69;33.06;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2)"
101;22072;Current Gene Therapy;journal;18755631, 15665232;1.323;Q1;75;43;143;3620;459;134;3.04;84.19;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
102;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.323;Q1;229;838;2484;36095;11257;2449;4.05;43.07;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
103;25240;Toxicology Letters;journal;03784274, 18793169;1.302;Q1;150;293;878;12808;3546;851;4.01;43.71;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
104;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;1.289;Q1;175;721;2376;36288;11143;2371;4.81;50.33;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmacology (Q1)"
105;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.275;Q1;95;47;170;3081;428;167;2.45;65.55;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
106;21100853576;Bulletin of Faculty of Pharmacy, Cairo University;journal;11100931;1.273;Q1;1;0;1;0;8;1;8;0;Egypt;Africa/Middle East;;;"Pharmaceutical Science (Q1); Pharmacy (Q1)"
107;29311;Current Cancer Drug Targets;journal;15680096, 18735576;1.271;Q1;96;84;221;7769;819;205;2.81;92.49;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1); Cancer Research (Q2)"
108;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;1.262;Q1;144;334;768;15726;3446;757;4.11;47.08;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
109;4000148019;AAPS Journal;journal;15507416;1.259;Q1;118;144;389;6220;1639;379;3.65;43.19;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q1)
110;4000148406;Clinical Toxicology;journal;15569519, 15563650;1.256;Q1;98;137;453;3465;1215;299;3.01;25.29;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
111;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;1.256;Q1;66;154;298;4489;694;265;2.08;29.15;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
112;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;1.25;Q1;98;163;513;7570;1840;507;3;46.44;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
113;21790;Antiviral Therapy;journal;20402058, 13596535;1.247;Q1;89;96;349;2850;871;339;2.32;29.69;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Infectious Diseases (Q2)"
114;22378;Vascular Pharmacology;journal;18793649, 15371891;1.247;Q1;100;126;261;7703;918;252;3.67;61.13;United States;Northern America;Elsevier Inc.;2002-2021;"Pharmacology (Q1); Molecular Medicine (Q2); Physiology (Q2)"
115;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1.235;Q1;103;97;344;2793;870;310;2.29;28.79;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
116;16088;Journal of Nanobiotechnology;journal;14773155;1.234;Q1;84;80;199;4555;1067;198;5.28;56.94;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
117;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.231;Q1;78;114;325;2763;910;305;2.46;24.24;United States;Northern America;Preston Publications;1977-2021;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Environmental Chemistry (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
118;24785;Alcohol;journal;07418329;1.229;Q1;83;76;244;3835;655;235;2.86;50.46;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Neurology (Q2)"
119;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.223;Q1;96;77;257;3418;810;247;2.81;44.39;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
120;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.223;Q1;70;43;134;2190;344;127;2.51;50.93;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
121;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.21;Q1;109;126;411;11124;1526;405;3.78;88.29;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
122;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;1.208;Q1;31;15;67;912;283;67;4.65;60.8;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
123;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.206;Q1;139;115;721;6419;2207;715;3.17;55.82;United States;Northern America;Elsevier Inc.;1973-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2)"
124;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;1.204;Q1;114;277;884;9362;2803;873;2.96;33.8;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
125;23053;Journal of Natural Products;journal;01633864, 15206025;1.202;Q1;147;400;1112;14257;4017;1105;3.45;35.64;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
126;29712;Clinical Therapeutics;journal;1879114X, 01492918;1.19;Q1;140;249;705;9196;2037;613;2.73;36.93;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
127;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.187;Q1;163;218;640;13220;2320;627;3.57;60.64;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
128;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.181;Q1;120;144;554;5905;1778;523;3.26;41.01;United States;Northern America;Landes Bioscience;2002-2021;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2); Oncology (Q2)"
129;7700153108;International Journal of Nanomedicine;journal;11782013, 11769114;1.174;Q1;145;487;1502;23728;7304;1473;4.54;48.72;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Nanoscience and Nanotechnology (Q2)"
130;20664;Current Drug Targets;journal;18735592, 13894501;1.172;Q1;107;245;469;26706;1423;426;2.57;109;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
131;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;1.167;Q1;91;139;502;11318;1742;489;3.42;81.42;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
132;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;1.163;Q1;104;92;258;4378;896;255;3.04;47.59;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q1)"
133;4400151608;ChemMedChem;journal;18607187, 18607179;1.156;Q1;106;320;780;13373;2160;771;2.8;41.79;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
134;18073;NeuroToxicology;journal;18729711, 0161813X;1.148;Q1;122;167;406;9550;1380;384;3.27;57.19;Netherlands;Western Europe;Elsevier;1979-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
135;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1.146;Q1;94;35;81;1388;313;80;2.38;39.66;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2); Genetics (clinical) (Q3)"
136;18071;Neurotoxicity Research;journal;14763524, 10298428;1.142;Q1;78;102;216;7623;723;215;3.1;74.74;United States;Northern America;Springer New York;1999, 2001-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
137;19700175143;Pharmacognosy Reviews (discontinued);journal;09737847, 09762787;1.14;Q1;54;20;68;1475;309;67;4.65;73.75;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmacology (Q1); Plant Science (Q1)"
138;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.129;Q1;100;33;98;4523;401;94;4.15;137.06;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
139;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;1.127;Q1;52;59;184;2833;507;179;2.94;48.02;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
140;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;1.116;Q1;68;105;306;9743;1130;304;3.65;92.79;United Kingdom;Western Europe;Informa Healthcare;2006-2021;Drug Discovery (Q1)
141;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.112;Q1;213;244;854;11410;3290;844;3.55;46.76;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
142;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;1.098;Q1;114;179;633;5787;1812;563;2.94;32.33;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
143;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;1.095;Q1;48;58;168;2165;422;161;2.51;37.33;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
144;17067;Phytomedicine;journal;09447113, 1618095X;1.094;Q1;127;199;587;8722;2288;573;3.91;43.83;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
145;20473;Life Sciences;journal;18790631, 00243205;1.093;Q1;174;498;1061;25783;3376;1048;3.18;51.77;United States;Northern America;Elsevier Inc.;1962-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
146;18966;Mutagenesis;journal;02678357, 14643804;1.093;Q1;95;73;230;3495;629;226;2.71;47.88;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q3)"
147;19600166302;Current Molecular Pharmacology;journal;18744702;1.09;Q1;42;37;73;3579;166;62;2.19;96.73;United Arab Emirates;Middle East;Bentham Science Publishers;2008-2021;"Drug Discovery (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
148;21333;European Journal of Pharmacology;journal;00142999, 18790712;1.09;Q2;189;588;2070;31023;6528;2061;3.11;52.76;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q2)
149;22432;International Immunopharmacology;journal;18781705, 15675769;1.088;Q2;119;407;1218;18308;3999;1205;3.22;44.98;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
150;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;1.087;Q1;205;693;2022;39444;7461;2010;3.42;56.92;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q1); Pharmacology (Q2)"
151;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.085;Q2;183;276;956;36282;3467;901;3.37;131.46;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
152;4700152848;PPAR Research;journal;16874757, 16874765;1.079;Q1;52;31;88;2200;246;85;2.85;70.97;United States;Northern America;Hindawi Publishing Corporation;2006-2021;"Drug Discovery (Q1); Pharmacology (medical) (Q2)"
153;24028;Reproductive Toxicology;journal;08906238, 18731708;1.078;Q2;117;182;423;9486;1319;408;2.48;52.12;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q2)
154;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.069;Q1;166;581;1906;75638;5755;1740;2.71;130.19;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q2)"
155;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.067;Q2;71;66;207;3398;554;170;2.52;51.48;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
156;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;1.057;Q1;77;110;328;9821;1295;325;3.15;89.28;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
157;19700178100;Nanotechnology, Science and Applications;journal;11778903;1.048;Q1;30;4;12;548;99;12;8.25;137;New Zealand;Pacific Region;Dove Medical Press Limited;2010-2012, 2014-2021;"Biomedical Engineering (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Nanoscience and Nanotechnology (Q2)"
158;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;1.046;Q2;121;195;519;7813;1478;491;2.76;40.07;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
159;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;1.041;Q1;46;34;73;3074;252;69;3.24;90.41;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (medical) (Q2)"
160;10300153301;Expert Review of Clinical Pharmacology;journal;17512433, 17512441;1.04;Q1;46;156;228;11087;652;208;2.82;71.07;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
161;20051;BioDrugs;journal;11738804, 1179190X;1.035;Q2;71;48;139;2995;469;131;3.13;62.4;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
162;24652;Chemico-Biological Interactions;journal;00092797;1.029;Q2;128;332;823;16824;2844;809;3.45;50.67;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
163;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;1.027;Q1;57;146;427;4959;1311;400;3.55;33.97;United Kingdom;Western Europe;John Wiley and Sons Ltd;2009-2021;"Analytical Chemistry (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1); Environmental Chemistry (Q2)"
164;22410;Inflammation Research;journal;1420908X, 10233830;1.025;Q2;94;97;327;4549;938;324;2.79;46.9;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
165;25224;Toxicology in Vitro;journal;18793177, 08872333;1.025;Q2;112;188;754;9172;2566;740;3.22;48.79;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
166;16573;Phytotherapy Research;journal;10991573, 0951418X;1.016;Q2;140;217;775;11891;2773;770;3.59;54.8;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
167;19034;Microbial Drug Resistance;journal;10766294, 19318448;1.015;Q2;72;96;261;3569;659;247;2.46;37.18;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q1); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Immunology (Q3)"
168;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.014;Q2;83;92;239;4945;582;234;2.41;53.75;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
169;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;1.014;Q2;83;238;735;17781;2299;716;3.37;74.71;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
170;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;1.014;Q2;92;113;356;5159;1046;354;2.92;45.65;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q2)"
171;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;1.01;Q1;186;424;1285;18556;4011;1221;3.04;43.76;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
172;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;1.009;-;144;68;246;2910;734;239;2.34;42.79;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Molecular Medicine (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3)"
173;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876, 2221285X;1.006;Q1;48;183;149;2756;622;146;3.99;15.06;China;Asiatic Region;Shenyang Pharmaceutical University;2009-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
174;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.004;Q2;39;55;152;1667;193;145;1.2;30.31;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
175;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1.003;Q2;90;144;500;12082;1244;440;2.46;83.9;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2)"
176;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;1.003;Q2;81;90;271;4954;865;271;3.29;55.04;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
177;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;1;Q2;87;118;410;3638;1094;409;2.77;30.83;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
178;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.993;Q1;44;79;214;3242;637;213;2.98;41.04;South Korea;Asiatic Region;Korean Society of Applied Pharmacology;2008-2021;"Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
179;19700175230;Drug Design, Development and Therapy;journal;11778881;0.993;Q1;71;363;908;15594;2900;893;3.04;42.96;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
180;21207;Drug Discovery Today: Technologies;journal;17406749;0.99;Q1;53;35;142;1518;408;125;2.59;43.37;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Biotechnology (Q1); Drug Discovery (Q1); Molecular Medicine (Q2)"
181;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0.984;Q1;171;660;2274;28868;7172;2262;3.1;43.74;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
182;19700188360;Pharmaceutics;journal;19994923;0.984;Q1;68;34;109;2038;437;107;3.67;59.94;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010-2021;Pharmaceutical Science (Q1)
183;19700188352;Toxins;journal;20726651;0.984;Q2;91;371;708;22872;2546;693;3.14;61.65;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q2)"
184;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;0.976;Q1;46;70;160;3946;479;148;3.13;56.37;United States;Northern America;Springer Publishing Company;2011-2021;Pharmaceutical Science (Q1)
185;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.972;Q1;54;106;267;3666;636;228;2.27;34.58;United States;Northern America;Elsevier Inc.;2005-2021;"Pharmaceutical Science (Q1); Pharmacy (Q1)"
186;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;0.97;Q2;76;165;564;11139;1441;450;2.63;67.51;United Kingdom;Western Europe;Future Science;2009-2021;"Drug Discovery (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
187;4000151703;Core Evidence (discontinued);journal;15551741, 1555175X;0.965;Q2;25;5;28;371;113;27;4.14;74.2;New Zealand;Pacific Region;Dove Medical Press Ltd.;2005-2018;"Medicine (miscellaneous) (Q1); Reviews and References (medical) (Q1); Pharmacology (Q2)"
188;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.96;Q2;103;64;224;3746;591;206;2.41;58.53;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q2); Cellular and Molecular Neuroscience (Q3); Developmental Neuroscience (Q3)"
189;21100200427;Human Vaccines and Immunotherapeutics;journal;21645515, 2164554X;0.957;Q2;69;443;1324;18555;2756;1093;1.98;41.88;United States;Northern America;Landes Bioscience;2012-2021;"Medicine (miscellaneous) (Q1); Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
190;14805;Steroids;journal;0039128X, 18785867;0.957;Q2;107;170;571;7348;1656;561;2.81;43.22;United States;Northern America;Elsevier Inc.;1963-2021;"Organic Chemistry (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
191;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.945;Q2;78;33;114;1379;327;111;3.11;41.79;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
192;22411;Inflammopharmacology;journal;09254692, 15685608;0.941;Q2;55;43;109;1799;334;104;2.97;41.84;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)"
193;21100218055;"BMC pharmacology &amp; toxicology";journal;20506511;0.94;Q2;34;62;180;2499;521;177;2.79;40.31;United Kingdom;Western Europe;BioMed Central Ltd.;2012-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
194;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.939;Q2;104;124;450;6221;1109;429;2.35;50.17;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
195;18077;Fitoterapia;journal;0367326X, 18736971;0.937;Q2;110;230;739;8222;2404;739;3.07;35.75;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
196;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.928;Q2;88;138;403;11225;1371;399;3.37;81.34;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
197;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.922;Q2;91;157;478;8154;1560;476;3.32;51.94;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
198;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;0.92;Q1;133;641;1479;22281;5094;1466;3.54;34.76;Netherlands;Western Europe;Elsevier;1983-2022;"Analytical Chemistry (Q1); Pharmaceutical Science (Q1); Clinical Biochemistry (Q2); Drug Discovery (Q2); Spectroscopy (Q2)"
199;11700154733;Journal of Biomedical Nanotechnology;journal;15507041, 15507033;0.916;Q1;80;173;661;9546;3272;660;4.81;55.18;United States;Northern America;American Scientific Publishers;2007-2020;"Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Nanoscience and Nanotechnology (Q2)"
200;19700194010;MedChemComm;journal;20402503, 20402511;0.913;Q1;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Royal Society of Chemistry;2010-2019;"Pharmaceutical Science (Q1); Biochemistry (Q2)"
201;26767;Altex;journal;1868596X, 18688551;0.911;Q2;57;40;127;2158;408;107;2.8;53.95;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
202;26512;Tetrahedron;journal;14645416, 00404020;0.91;Q2;226;997;3547;53766;9796;3533;2.82;53.93;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2)"
203;110172;Progress in Drug Research;book series;0071786X;0.905;Q1;44;33;31;189;116;26;3.74;5.73;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q3)"
204;21167;Pharmacogenomics;journal;14622416, 17448042;0.904;Q2;94;177;606;9598;1420;528;2.22;54.23;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
205;21100197929;Toxicological Research;journal;19768257, 22342753;0.904;Q2;35;41;152;1528;381;152;3.16;37.27;South Korea;Asiatic Region;Koreal Association of Medical Journal Editors;2008-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
206;21100825823;Pharmacology Research and Perspectives;journal;20521707;0.896;Q1;32;71;174;3520;383;172;2.26;49.58;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neurology (Q2)"
207;23155;Current Vascular Pharmacology;journal;15701611, 18756212;0.89;Q2;63;87;299;5574;626;252;2.14;64.07;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
208;25214;Toxicologic Pathology;journal;15331601, 01926233;0.886;Q2;112;106;324;4150;727;321;2.14;39.15;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q1); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
209;21100225613;Human gene therapy methods;journal;19466536, 19466544;0.885;Q2;31;24;103;794;216;101;1.97;33.08;United States;Northern America;Mary Ann Liebert Inc.;2012-2019;"Applied Microbiology and Biotechnology (Q2); Pharmacology (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Medicine (Q3)"
210;144790;Marine Drugs;journal;16603397;0.883;Q2;128;234;1028;15798;4252;1026;4.06;67.51;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery (Q2)
211;20663;Current Drug Metabolism;journal;18755453, 13892002;0.881;Q2;111;86;242;10388;735;223;2.77;120.79;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q2); Pharmacology (Q2)"
212;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;0.879;Q2;122;294;694;31134;1947;611;2.61;105.9;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
213;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;0.875;Q1;29;11;26;733;118;26;5.64;66.64;United States;Northern America;Springer Science + Business Media;2010-2021;"Pharmaceutical Science (Q1); Biomedical Engineering (Q2); Oncology (Q2); Physical and Theoretical Chemistry (Q2)"
214;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.873;Q2;79;317;419;14565;1434;418;4.17;45.95;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
215;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.869;Q2;58;56;218;1784;348;132;1.95;31.86;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q2); Molecular Medicine (Q3)"
216;130063;Pharmacological Reports;journal;17341140;0.866;Q2;87;191;523;8952;1519;520;2.78;46.87;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
217;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.864;Q2;109;722;568;32524;1711;565;3.04;45.05;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
218;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;0.861;Q2;115;120;352;6725;927;352;2.57;56.04;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q2)"
219;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.854;Q2;113;94;247;5428;670;245;2.63;57.74;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Cell Biology (Q3); Physiology (Q3)"
220;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.849;Q1;154;1138;3481;35132;9337;3479;2.67;30.87;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
221;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.845;Q2;107;151;424;6251;894;400;2.03;41.4;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
222;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.843;Q2;66;111;199;4950;670;196;3.51;44.59;United States;Northern America;Academic Press Inc.;1971-2021;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
223;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.84;Q2;77;64;212;2749;546;211;2.45;42.95;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
224;26370;Molecules;journal;14203049;0.825;Q1;171;1763;3657;90740;12138;3643;3.22;51.47;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Analytical Chemistry (Q1); Chemistry (miscellaneous) (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
225;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.82;Q2;27;0;18;0;30;16;0;0;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q2); Molecular Medicine (Q3)"
226;19300156901;Dose-Response;journal;15593258;0.818;Q2;41;18;127;593;288;121;2.44;32.94;United States;Northern America;International Dose-Response Society;2008-2021;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
227;20578;Journal of Food and Drug Analysis;journal;10219498;0.817;Q2;63;104;255;4068;727;250;3.38;39.12;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q1); Pharmacology (Q2)"
228;19700201201;EPMA Journal;journal;18785077, 18785085;0.814;Q2;39;23;54;1479;243;54;3.65;64.3;United Kingdom;Western Europe;BioMed Central Ltd.;2010-2021;"Biochemistry (medical) (Q2); Drug Discovery (Q2); Health Policy (Q2)"
229;21100241624;International Journal of Genomics;journal;2314436X, 23144378;0.814;Q1;29;54;156;2395;392;150;2.91;44.35;Egypt;Africa/Middle East;Hindawi Limited;2013-2021;"Pharmaceutical Science (Q1); Biochemistry (Q2); Genetics (Q3); Molecular Biology (Q3)"
230;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.814;Q2;93;124;360;6203;869;345;2.53;50.02;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
231;21100258853;F1000Research;journal;20461402;0.813;Q1;72;706;805;36121;1152;765;1.43;51.16;United Kingdom;Western Europe;;2012-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Immunology and Microbiology (miscellaneous)  (Q3)"
232;4000150314;Chemical Biology and Drug Design;journal;17470277;0.812;-;82;182;537;7080;1425;531;2.33;38.9;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q2); Molecular Medicine (Q3)"
233;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;0.807;Q2;100;198;464;13188;1239;429;2.42;66.61;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q2); Cancer Research (Q3); Molecular Medicine (Q3)"
234;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.806;Q2;47;59;164;3036;403;158;2.05;51.46;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
235;25075;Ecotoxicology;journal;09639292, 15733017;0.797;Q2;97;170;548;9542;1337;544;2.11;56.13;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
236;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.796;Q2;80;167;663;5875;1575;658;2.31;35.18;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
237;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.795;Q2;75;89;228;3896;633;223;2.49;43.78;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q2); Toxicology (Q2)"
238;25109;Inhalation Toxicology;journal;08958378, 10917691;0.794;Q2;90;71;258;3324;563;253;1.84;46.82;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
239;19700174889;Drug Target Insights;journal;11773928;0.79;Q1;13;8;18;333;58;18;1.83;41.63;Italy;Western Europe;AboutScience Srl;2008-2009, 2011-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Clinical Biochemistry (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
240;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;0.79;Q2;52;70;228;1466;437;190;1.82;20.94;United States;Northern America;Springer New York;2005-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
241;19700175819;Patient Preference and Adherence;journal;1177889X;0.79;Q1;54;254;478;9951;1088;467;2.04;39.18;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Social Sciences (miscellaneous) (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2)"
242;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.783;Q2;49;122;355;6205;666;310;1.77;50.86;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2021;"Biochemistry (medical) (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2)"
243;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.78;Q2;96;159;397;5579;967;391;2.51;35.09;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
244;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.776;Q2;42;7;94;143;285;90;3.11;20.43;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
245;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.774;Q2;56;43;127;1682;302;124;2.23;39.12;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
246;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.773;Q2;88;279;726;11745;1998;724;2.6;42.1;Netherlands;Western Europe;Elsevier;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
247;16533;Phytochemical Analysis;journal;09580344, 10991565;0.773;Q2;76;43;206;1328;537;203;2.4;30.88;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Plant Science (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
248;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.771;Q1;73;51;152;2228;391;148;2.57;43.69;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
249;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.769;Q2;64;44;79;1984;221;79;2.46;45.09;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
250;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.767;Q2;62;67;208;2554;500;205;2.09;38.12;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
251;19374;AAPS PharmSciTech;journal;15309932;0.766;Q1;101;147;426;6034;1092;423;2.41;41.05;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
252;22319;Toxicon;journal;18793150, 00410101;0.766;Q2;133;256;809;11628;2023;789;2.23;45.42;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q2)
253;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.765;Q1;59;211;378;8586;931;365;2.52;40.69;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
254;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.762;Q2;51;38;131;3609;371;127;3.16;94.97;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
255;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.759;Q1;95;93;276;5219;814;270;2.78;56.12;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
256;26514;Tetrahedron Letters;journal;00404039, 18733581;0.754;Q2;173;1371;4880;55311;11336;4879;2.37;40.34;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3)"
257;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.749;Q2;70;66;276;2741;676;272;2.18;41.53;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3)"
258;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.74;Q1;124;155;526;6760;1439;520;2.46;43.61;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
259;19700188217;Bioanalysis;journal;17576180, 17576199;0.738;Q1;62;221;908;8422;1956;757;2.15;38.11;United Kingdom;Western Europe;Future Science;2009-2021;"Medical Laboratory Technology (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Medicine (miscellaneous) (Q2)"
260;5800173383;Current Clinical Pharmacology;journal;15748847, 22123938;0.733;Q1;0;0;0;0;0;0;0;0;United Arab Emirates;Middle East;Bentham Science Publishers;2006-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
261;15840;Journal of Antibiotics;journal;00218820, 18811469;0.733;Q2;84;143;409;4036;951;388;2.32;28.22;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
262;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.728;Q2;95;187;377;17417;1115;354;2.45;93.14;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
263;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.724;Q2;112;278;618;11609;1459;566;2.33;41.76;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
264;21100455212;Biomedical Reports;journal;20499434, 20499442;0.723;Q1;29;273;25;8872;62;25;2.48;32.5;Greece;Western Europe;Spandidos Publications;2014-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
265;4700152278;Drugs in Context;journal;17404398, 17451981;0.718;Q2;26;11;40;375;118;36;3.78;34.09;United Kingdom;Western Europe;BioExcel Publishing Ltd.;2006-2008, 2012-2021;"Pharmacology (Q2); Molecular Medicine (Q3)"
266;21100238633;BioImpacts;journal;22285652, 22285660;0.716;Q1;37;30;92;1351;248;82;2.33;45.03;Iran;Middle East;Tabriz University of Medical Sciences;2011-2021;"Pharmaceutical Science (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
267;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.716;Q2;62;86;258;2671;338;255;1.22;31.06;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
268;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0.715;Q1;16;7;48;174;61;33;1.54;24.86;United States;Northern America;IPEC-Americas;2010-2021;"Food Science (Q1); Pharmaceutical Science (Q1)"
269;22205;Saudi Pharmaceutical Journal;journal;13190164;0.715;Q1;57;90;229;3028;658;221;2.46;33.64;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
270;21100469670;Antibiotics;journal;20796382;0.714;Q1;47;37;111;2457;232;108;2.05;66.41;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010, 2012-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Infectious Diseases (Q2); Microbiology (medical) (Q2); Pharmacology (medical) (Q2); Biochemistry (Q3); Microbiology (Q3)"
271;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.714;Q2;64;44;161;1690;317;156;1.74;38.41;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
272;19700175023;Journal of Toxicology;journal;16878205, 16878191;0.714;Q2;39;23;75;1263;169;75;2.02;54.91;Egypt;Africa/Middle East;Hindawi Limited;2010-2021;"Pharmacology (Q2); Toxicology (Q2)"
273;25093;Environmental Toxicology;journal;15227278, 15204081;0.713;Q2;81;189;356;9030;882;356;2.42;47.78;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
274;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0.709;Q2;37;47;232;847;342;160;1.08;18.02;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
275;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;0.706;Q1;76;14;45;2887;311;45;7;206.21;United States;Northern America;Begell House Inc.;1984-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
276;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.704;Q1;50;91;287;3029;673;287;2.37;33.29;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2)"
277;21100793213;Current Pharmacology Reports;journal;2198641X;0.702;Q2;26;34;42;3104;101;42;2.4;91.29;Switzerland;Western Europe;Springer International Publishing AG;2015-2021;"Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Genetics (Q3)"
278;10900153302;Biomarker Insights;journal;11772719;0.699;Q2;35;29;96;1744;194;94;1.78;60.14;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2021;"Biochemistry (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
279;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.694;Q2;63;49;217;1645;438;213;1.69;33.57;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Oncology (Q3)"
280;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.693;Q1;63;177;468;5030;888;443;1.79;28.42;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmaceutical Science (Q1); Pharmacy (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q2)"
281;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.686;Q2;90;213;667;8914;1531;657;2.24;41.85;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
282;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.685;Q2;64;104;364;3403;696;336;1.73;32.72;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
283;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.682;Q2;52;20;111;881;176;110;1.5;44.05;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Developmental Biology (Q3); Embryology (Q3)"
284;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.682;Q2;90;91;331;3971;517;323;1.44;43.64;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Environmental Science (miscellaneous) (Q2); Mathematics (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Neuroscience (miscellaneous) (Q3)"
285;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.681;Q1;61;48;147;1600;386;144;2.18;33.33;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
286;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.68;Q2;33;73;219;2723;431;219;2.2;37.3;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q2); Physiology (Q3)"
287;16948;Chirality;journal;1520636X, 08990042;0.677;Q2;80;107;383;3785;843;380;2.07;35.37;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
288;21744;Planta Medica;journal;14390221, 00320943;0.674;Q1;122;168;598;7416;1326;584;2.17;44.14;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
289;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.673;Q1;69;63;222;2207;491;206;2.19;35.03;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
290;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.669;Q2;76;123;333;3406;692;331;1.91;27.69;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
291;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.667;Q2;122;287;885;9808;1761;866;1.89;34.17;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2)"
292;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.664;Q3;32;44;152;1439;275;152;1.86;32.7;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
293;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.661;Q2;93;176;591;7565;1460;587;2.39;42.98;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3)"
294;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.659;Q2;96;123;369;4442;879;343;2.23;36.11;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
295;25898;Journal of Peptide Science;journal;10752617, 10991387;0.655;Q2;68;87;326;3779;579;320;2;43.44;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
296;20634;Journal of Texture Studies;journal;00224901, 17454603;0.654;Q2;57;50;142;2121;259;139;1.47;42.42;United States;Northern America;Wiley-Blackwell;1969-2021;"Food Science (Q2); Pharmaceutical Science (Q2)"
297;19900192900;Molecular Informatics;journal;18681751, 18681743;0.653;Q2;70;69;224;3488;429;215;1.94;50.55;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q3)"
298;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.652;Q1;38;26;69;1367;176;69;2.11;52.58;United States;Northern America;Hindawi Publishing Corporation;2009-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
299;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.652;Q2;99;356;1053;5756;1231;642;1.04;16.17;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
300;19700200821;Therapeutic Delivery;journal;20415990, 20416008;0.65;Q2;52;73;363;4191;764;322;1.86;57.41;United Kingdom;Western Europe;Future Science;2010-2021;Pharmaceutical Science (Q2)
301;20770;Drug Delivery;journal;10717544, 15210464;0.649;Q2;72;372;221;16835;740;221;3.17;45.26;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
302;13671;Biologicals;journal;10958320, 10451056;0.648;Q2;60;77;192;2357;353;189;1.91;30.61;United States;Northern America;Academic Press Inc.;1990-2021;"Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3)"
303;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;0.647;Q1;42;80;263;3159;621;261;2.36;39.49;Iran;Middle East;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
304;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.637;Q2;80;76;163;2160;322;157;1.69;28.42;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
305;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;0.636;Q2;88;152;393;9634;825;358;2.21;63.38;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Biotechnology (Q2); Pharmaceutical Science (Q2)"
306;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.627;Q1;48;166;513;5323;954;499;1.7;32.07;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
307;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.62;Q2;34;17;51;863;102;51;1.84;50.76;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
308;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.616;Q3;42;10;87;374;147;79;1.33;37.4;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
309;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.614;Q2;47;24;211;747;474;194;2.06;31.13;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
310;21100239265;PharmaNutrition;journal;22134344;0.613;Q3;23;18;72;1392;146;67;1.65;77.33;Netherlands;Western Europe;Elsevier BV;2013-2021;"Food Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
311;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.612;Q1;61;102;360;4208;693;341;1.88;41.25;China;Asiatic Region;Zhejiang University Press;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Veterinary (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
312;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.609;Q3;52;84;259;2098;224;249;1.01;24.98;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3); Statistics and Probability (Q3)"
313;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.609;Q3;40;98;146;4626;289;145;2.04;47.2;United States;Northern America;Informa Healthcare;2004-2021;"Immunology (Q3); Toxicology (Q3)"
314;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.603;Q2;48;94;300;2301;523;295;1.74;24.48;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Spectroscopy (Q2); Biochemistry (Q3)"
315;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.597;Q1;35;150;502;2314;452;275;0.85;15.43;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Anesthesiology and Pain Medicine (Q2); Pharmacology (medical) (Q2)"
316;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.596;Q3;58;103;297;3264;513;289;1.88;31.69;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
317;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.592;Q2;81;40;156;3079;361;155;1.74;76.98;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
318;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.587;Q2;66;84;251;2826;500;244;1.82;33.64;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Chemistry (miscellaneous) (Q2); Colloid and Surface Chemistry (Q2); Dermatology (Q2); Drug Discovery (Q2); Pharmaceutical Science (Q2); Aging (Q3)"
319;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148, 22123334;0.587;Q2;25;20;61;1492;117;59;1.71;74.6;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2017;"Biochemistry (medical) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3)"
320;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.586;Q3;53;92;288;3403;510;221;1.64;36.99;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
321;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.585;Q3;42;56;114;1755;219;114;1.6;31.34;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Public Health, Environmental and Occupational Health (Q2); Safety Research (Q2); Toxicology (Q3)"
322;21100241601;Toxicology Research;journal;2045452X, 20454538;0.584;Q3;37;129;260;6408;566;256;2;49.67;United Kingdom;Western Europe;Oxford University Press;2012-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3)"
323;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.583;Q3;46;80;257;3860;486;256;1.85;48.25;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3)"
324;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.575;Q1;91;151;445;4651;736;445;1.77;30.8;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
325;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.575;Q3;32;37;120;1346;208;113;1.7;36.38;United Kingdom;Western Europe;Centro de Estudos de Venenos e Animais Peconhentos;2006-2021;"Animal Science and Zoology (Q2); Infectious Diseases (Q3); Parasitology (Q3); Toxicology (Q3)"
326;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.575;Q2;72;394;676;16559;1384;676;1.97;42.03;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
327;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.573;Q3;93;162;409;6080;1145;379;2.86;37.53;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Toxicology (Q3)"
328;5800228222;Journal of Pharmaceutical Innovation;journal;18725120, 19398042;0.572;Q2;31;30;90;1468;223;90;2.64;48.93;United States;Northern America;Springer New York;2006-2021;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
329;21194;Pharmacology;journal;00317012, 14230313;0.569;Q3;60;76;249;2417;422;247;1.64;31.8;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
330;23039;Journal of Liposome Research;journal;08982104, 15322394;0.566;Q2;53;33;108;1370;233;107;1.7;41.52;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q2)
331;21264;Drugs in R and D;journal;11796901, 11745886;0.563;Q3;47;37;107;1399;234;104;2.23;37.81;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q3)
332;25106;Human and Experimental Toxicology;journal;09603271;0.562;Q3;82;138;392;5261;708;384;1.85;38.12;United States;Northern America;SAGE Publications Inc.;1981-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
333;25171;Mycotoxin Research;journal;18671632, 01787888;0.562;Q3;40;24;87;1326;191;85;2.81;55.25;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q2); Microbiology (Q3); Toxicology (Q3)"
334;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.561;Q2;65;86;273;3844;686;272;2.34;44.7;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
335;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.56;Q3;87;114;484;4976;822;455;1.6;43.65;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Physiology (Q3); Physiology (medical) (Q3)"
336;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.559;Q3;40;71;152;4373;359;145;2.36;61.59;Netherlands;Western Europe;Wageningen Academic Publishers;2009-2021;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
337;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.554;Q3;55;27;99;1165;143;89;1.38;43.15;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
338;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;0.553;Q2;20;29;29;788;47;29;1.55;27.17;India;Asiatic Region;International Journal of Applied Pharmaceutics;2011-2021;Pharmaceutical Science (Q2)
339;6400153120;Chinese Medicine;journal;17498546;0.551;Q3;45;48;88;2265;167;86;1.74;47.19;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Complementary and Alternative Medicine (Q1); Pharmacology (Q3)"
340;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.548;Q2;65;104;214;4225;748;204;3.65;40.63;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2); Pharmaceutical Science (Q2)"
341;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.542;Q3;46;68;188;2733;318;186;1.66;40.19;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
342;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0.539;Q2;44;183;489;7256;870;483;1.74;39.65;Iran;Middle East;Mashhad University of Medical Sciences;2007-2021;"Drug Discovery (Q2); Biochemistry (Q3); Biophysics (Q3); Clinical Biochemistry (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
343;20570;Chemotherapy;journal;00093157, 14219794;0.536;Q2;58;46;156;1551;267;154;1.73;33.72;Switzerland;Western Europe;S. Karger AG;1960-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
344;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.535;Q1;69;200;624;4602;989;499;1.18;23.01;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
345;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.531;Q3;25;13;66;469;110;60;1.93;36.08;New Zealand;Pacific Region;Dove Medical Press Limited;2009-2021;"Health Policy (Q2); Pharmacology (Q3)"
346;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.531;Q2;62;116;394;4437;669;393;1.7;38.25;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
347;59665;Chinese Journal of Natural Medicines;journal;16723651;0.528;Q2;40;115;362;4188;728;362;1.88;36.42;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
348;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0.528;Q3;51;0;120;0;203;112;1.58;0;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2015;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
349;17700156705;Modern Trends in Pharmacopsychiatry;journal;16622685, 16624505;0.524;Q3;0;0;0;0;0;0;0;0;Switzerland;Western Europe;S. Karger AG;2009-2010, 2013, 2015, 2017;"Medicine (miscellaneous) (Q2); Psychiatry and Mental Health (Q2); Pharmacology (Q3)"
350;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.523;Q3;76;279;792;7913;1221;788;1.52;28.36;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
351;21192;Drug Development Research;journal;02724391, 10982299;0.522;Q2;62;53;193;2982;310;189;2.1;56.26;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q2)
352;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.521;Q3;52;88;199;2535;276;176;1.26;28.81;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
353;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X, 22124071;0.521;Q2;0;0;0;0;0;0;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2020;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Infectious Diseases (Q3); Pharmacology (medical) (Q3)"
354;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.52;Q3;53;61;215;2910;324;208;1.6;47.7;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
355;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;0.518;Q2;18;45;101;1140;70;93;0.5;25.33;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Pharmaceutical Science (Q2); Statistics and Probability (Q3)"
356;21100212330;Drug Discoveries and Therapeutics;journal;1881784X, 18817831;0.515;Q2;27;47;102;490;176;100;1.67;10.43;Japan;Asiatic Region;"International Advancement Center for Medicine &amp; Health Research Co., Ltd. (IACMHR Co., Ltd.)";1997, 2010-2018, 2020;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
357;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.513;Q2;34;18;45;786;74;38;1.48;43.67;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2016;"Drug Discovery (Q2); Psychiatry and Mental Health (Q2); Pharmacology (medical) (Q3)"
358;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.51;Q3;47;30;91;1500;155;91;1.8;50;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
359;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.506;Q3;67;127;350;2177;373;308;0.84;17.14;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
360;130025;Current Drug Delivery;journal;15672018;0.504;Q2;65;169;236;9621;521;224;2.15;56.93;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science (Q2)
361;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.497;Q2;33;61;145;2029;299;145;2.04;33.26;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
362;130047;Current Drug Discovery Technologies;journal;15701638;0.496;Q2;44;23;85;1202;126;82;1.63;52.26;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery (Q2)
363;14822;Xenobiotica;journal;00498254, 13665928;0.492;Q3;82;125;358;4472;668;353;1.88;35.78;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
364;21100367469;Toxicology Reports;journal;22147500;0.487;Q3;46;102;294;4699;468;293;1.59;46.07;Ireland;Western Europe;Elsevier Scientific Publishers Ireland;2014-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
365;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.486;Q2;39;60;200;1558;246;171;1.13;25.97;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q2)"
366;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0.485;Q2;38;34;103;673;184;87;1.51;19.79;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2021;Pharmaceutical Science (Q2)
367;130031;Journal of Toxicologic Pathology;journal;09149198;0.484;Q3;30;43;124;1631;159;121;1.34;37.93;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
368;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.484;Q3;32;42;111;2198;145;97;1.42;52.33;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
369;23942;Biomedical Chromatography;journal;10990801, 02693879;0.483;Q2;68;257;733;7131;1272;723;1.7;27.75;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Pharmacology (Q3); Molecular Biology (Q4)"
370;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.481;Q3;62;210;373;9311;587;373;1.4;44.34;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
371;144963;Drug Discovery Today: Disease Models;journal;17406757;0.479;Q2;28;32;82;1405;82;73;0.79;43.91;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q2); Molecular Medicine (Q3)"
372;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.476;Q2;81;81;267;3900;501;267;1.79;48.15;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Pharmaceutical Science (Q2); Bioengineering (Q3); Colloid and Surface Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
373;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.475;Q3;30;44;190;2606;172;190;0.92;59.23;United States;Northern America;Current Medicine Group;2007-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
374;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.473;Q3;10;22;46;790;22;46;0.38;35.91;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Virology (Q4)"
375;16067;Reading Teacher;journal;00340561;0.47;Q3;53;94;249;2039;196;221;0.73;21.69;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q3); Pharmacology (medical) (Q3)"
376;24578;Mathematical Medicine and Biology;journal;14778599;0.466;Q3;46;21;58;942;80;58;1.2;44.86;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Applied Mathematics (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3)"
377;4500151530;Personalized Medicine;journal;17410541;0.464;Q3;33;64;236;2994;243;209;0.82;46.78;United Kingdom;Western Europe;Future Medicine Ltd.;2006-2021;"Medicine (miscellaneous) (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
378;29053;Molecular Diversity;journal;1573501X, 13811991;0.463;Q2;58;72;210;3693;417;210;1.81;51.29;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Drug Discovery (Q2); Information Systems (Q2); Medicine (miscellaneous) (Q2); Catalysis (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Molecular Biology (Q4)"
379;5800173386;Current Drug Safety;journal;15748863;0.462;Q3;37;52;121;2077;173;113;1.12;39.94;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q3)"
380;21100788810;Chemotherapy Research and Practice;journal;20902107;0.461;Q2;5;0;4;0;9;4;2.25;0;United States;Northern America;;;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Oncology (Q3); Pharmacology (medical) (Q3)"
381;21100241608;Journal of Nanomedicine and Nanotechnology (discontinued);journal;21577439;0.456;Q2;24;0;61;0;122;55;2.11;0;United States;Northern America;OMICS Publishing Group;2010-2014;"Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3)"
382;21100262305;Clinical Pharmacology in Drug Development;journal;21607648, 2160763X;0.455;Q2;26;58;181;1330;190;166;0.87;22.93;United States;Northern America;Wiley-Blackwell;2012-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q3)"
383;19700175244;Current Radiopharmaceuticals;journal;18744710, 18744729;0.453;Q3;26;32;68;1103;90;64;0.95;34.47;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2021;"Pharmacology (Q3); Radiology, Nuclear Medicine and Imaging (Q3)"
384;19700175858;Journal of Pharmacognosy and Phytotherapy (discontinued);journal;21412502;0.446;Q3;22;18;65;484;233;65;6.3;26.89;United States;Northern America;Academic Journals Inc.;2010-2017;Drug Discovery (Q3)
385;15340;Developments in Biologicals;journal;14246074, 16622960;0.445;Q3;38;0;22;0;25;21;0;0;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Biomaterials (Q3); Pharmacology (Q3); Immunology (Q4)"
386;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.442;Q3;74;102;269;3968;382;267;1.28;38.9;United States;Northern America;Wiley-Blackwell;1986-2021;"Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Drug Discovery (Q3); Molecular Medicine (Q4)"
387;21100819608;Emerging Contaminants;journal;24056650, 24056642;0.439;Q3;24;27;8;1381;19;7;2.38;51.15;China;Asiatic Region;KeAi Communications Co.;2015-2021;"Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
388;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.438;Q2;28;43;103;1403;132;99;1.18;32.63;Spain;Western Europe;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
389;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.434;Q3;85;133;579;4352;708;578;1.25;32.72;United States;Northern America;Wiley-Blackwell;1918-2021;"Biochemistry (Q3); Catalysis (Q3); Drug Discovery (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
390;19200156706;Pharmacognosy Magazine (discontinued);journal;09731296, 09764062;0.434;Q2;42;107;302;3392;457;301;1.47;31.7;India;Asiatic Region;Wolters Kluwer Medknow Publications;2008-2018, 2020-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
391;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.433;Q3;62;178;481;3246;545;400;1.13;18.24;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
392;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.432;Q2;40;60;181;892;181;161;0.81;14.87;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
393;19700174941;Pharmacognosy Research (discontinued);journal;09748490;0.432;Q3;37;66;180;2003;276;179;1.48;30.35;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2019, 2021;"Drug Discovery (Q3); Pharmacology (Q3)"
394;19700175004;Open Medicinal Chemistry Journal;journal;18741045;0.431;Q2;18;4;14;187;30;14;2.14;46.75;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2020;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
395;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.43;Q3;63;337;367;8916;391;341;1.16;26.46;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
396;21717;Die Pharmazie;journal;00317144;0.429;Q2;66;128;459;3869;633;458;1.32;30.23;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
397;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.429;Q3;20;135;331;913;160;124;0.52;6.76;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
398;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.427;Q2;36;31;92;1195;135;80;1.49;38.55;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
399;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;0.42;Q2;38;56;167;1882;290;167;2.16;33.61;China;Asiatic Region;Xi'an Jiaotong University;2011-2021;"Pharmaceutical Science (Q2); Pharmacy (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Electrochemistry (Q3); Spectroscopy (Q3)"
400;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.419;Q2;26;3;17;6;23;17;1.43;2;United States;Northern America;Lumitext Publishing;2009-2017, 2020-2021;"Pharmaceutical Science (Q2); Molecular Biology (Q4)"
401;19700175105;Open Drug Delivery Journal;journal;18741266;0.418;Q2;5;0;1;0;2;1;2;0;Netherlands;Western Europe;;;Pharmaceutical Science (Q2)
402;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.417;Q3;64;51;122;1713;129;104;1.08;33.59;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
403;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.417;-;31;88;235;1961;278;216;0.96;22.28;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q3)
404;21100318814;Pharmaceutical patent analyst;journal;20468954, 20468962;0.414;Q2;17;40;123;33;105;84;0.82;0.83;United Kingdom;Western Europe;Future Science;2012-2018, 2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
405;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.413;Q2;42;145;495;2916;625;494;1.23;20.11;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
406;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.412;Q3;50;58;167;2439;298;164;1.78;42.05;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Bioengineering (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
407;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.411;Q3;37;45;151;1803;224;143;1.48;40.07;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
408;19700175060;International Journal of PharmTech Research (discontinued);journal;09744304;0.411;Q2;48;464;872;15204;1904;872;2.72;32.77;India;Asiatic Region;Sphinx Knowledge House;2009-2016;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
409;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.41;Q3;28;13;45;574;66;45;1.53;44.15;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
410;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.409;Q3;34;13;94;820;160;93;1.43;63.08;Slovakia;Eastern Europe;Slovak Toxicology Society SETOX;2008-2020;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
411;21100218529;Value in Health Regional Issues;journal;22121099, 22121102;0.409;Q2;21;48;187;1398;144;169;0.67;29.13;United States;Northern America;Elsevier USA;2012-2021;"Economics, Econometrics and Finance (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3)"
412;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.408;Q3;33;112;227;3597;390;226;1.57;32.12;United States;Northern America;Begell House Inc.;2005-2021;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
413;5400152628;Revista Brasileira de Farmacognosia;journal;0102695X, 1981528X;0.408;Q2;50;110;316;4620;544;307;1.69;42;Brazil;Latin America;Springer Nature Switzerland AG;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
414;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.404;Q2;17;8;29;289;38;29;1.76;36.13;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
415;21100248874;Dilemas;journal;19835922, 21782792;0.403;-;9;25;98;893;24;95;0.27;35.72;Brazil;Latin America;Universidade Federal do Rio de Janeiro - UFRJ;2013-2021;"Law (Q2); Sociology and Political Science (Q2)"
416;4700152603;Medicinal Chemistry;journal;15734064, 18756638;0.399;Q3;46;94;294;4585;431;287;1.69;48.78;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;Drug Discovery (Q3)
417;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.398;Q2;50;251;1429;9599;2172;1429;1.46;38.24;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
418;21100219314;Applied and Translational Genomics;journal;22120661;0.397;Q2;21;32;86;833;94;65;1.05;26.03;Netherlands;Western Europe;Elsevier BV;2012-2016;"Pharmaceutical Science (Q2); Biotechnology (Q3); Molecular Biology (Q4)"
419;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.397;Q3;95;251;520;7514;691;520;1.23;29.94;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
420;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.397;Q3;50;73;239;2952;279;239;1.13;40.44;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
421;19700170617;EXCLI Journal;journal;16112156;0.394;Q3;43;66;325;2762;501;272;1.5;41.85;Germany;Western Europe;Leibniz Research Centre for Working Environment and Human Factors;2009-2021;"Animal Science and Zoology (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
422;21100444313;Sustainable Chemistry and Pharmacy;journal;23525541;0.392;Q2;27;17;10;946;17;9;1.7;55.65;Netherlands;Western Europe;Elsevier BV;2015-2021;"Pharmaceutical Science (Q2); Pollution (Q2); Environmental Chemistry (Q3); Management, Monitoring, Policy and Law (Q3)"
423;145693;Canadian Pharmacists Journal;journal;17151635;0.391;Q2;24;55;217;958;136;120;0.74;17.42;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmaceutical Science (Q2); Pharmacy (Q2)"
424;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.387;Q3;54;0;39;0;52;38;1.06;0;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Virology (Q4)"
425;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.387;Q3;69;129;412;3195;451;401;1.04;24.77;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
426;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.387;Q2;52;144;298;7165;395;293;1.39;49.76;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
427;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.385;Q3;32;66;219;1725;254;217;1.23;26.14;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q3)"
428;11200153563;Drug Metabolism Letters;journal;18740758, 18723128;0.383;Q2;28;37;61;1197;66;55;0.94;32.35;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2019, 2021;"Pharmaceutical Science (Q2); Biochemistry (medical) (Q3); Clinical Biochemistry (Q3); Pharmacology (medical) (Q3)"
429;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.382;Q3;62;60;205;3227;239;193;1.19;53.78;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
430;27210;In Vivo;journal;17917549, 0258851X;0.382;Q3;64;134;398;2439;441;398;1.1;18.2;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
431;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.381;Q3;51;205;531;6449;499;529;0.75;31.46;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
432;25864;Heterocycles;journal;03855414;0.373;Q3;66;199;663;7491;631;663;0.93;37.64;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Analytical Chemistry (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
433;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.368;Q3;53;61;194;1451;250;190;1.25;23.79;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
434;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.364;Q3;36;77;172;3365;199;169;1.14;43.7;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
435;19700180522;Molecular and Cellular Toxicology;journal;20928467, 1738642X;0.362;Q2;23;49;150;1698;200;150;1.47;34.65;Germany;Western Europe;Springer Verlag;2010-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
436;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.36;Q2;45;183;405;5712;440;404;0.94;31.21;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
437;19700174918;Clinical and Translational Science;journal;17528062, 17528054;0.36;Q2;48;39;289;1440;264;270;0.83;36.92;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q3)"
438;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.359;Q3;40;26;90;1309;77;76;0.7;50.35;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
439;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.359;Q3;28;0;44;0;59;41;1.55;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2015;"Cardiology and Cardiovascular Medicine (Q3); Drug Discovery (Q3); Pharmacology (medical) (Q3)"
440;19700175099;Topics in Medicinal Chemistry;book series;1862247X, 18622461;0.358;Q3;12;20;55;2711;41;51;0.75;135.55;Germany;Western Europe;Springer Verlag;2009-2012, 2014-2021;"Drug Discovery (Q3); Molecular Medicine (Q4)"
441;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.357;Q2;23;125;332;2783;220;323;0.68;22.26;United States;Northern America;Elsevier Inc.;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacy (Q2)"
442;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.356;Q2;61;118;324;3163;397;321;0.9;26.81;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q2)
443;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;0.356;Q2;24;50;114;1576;161;108;1.25;31.52;Netherlands;Western Europe;Kowsar Publishing Company;2011-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
444;35190;Revista Espanola de Quimioterapia;journal;02143429;0.356;Q3;26;93;185;358;126;154;0.48;3.85;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
445;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.353;Q2;60;44;120;1338;202;120;1.49;30.41;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
446;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.353;Q2;23;21;58;706;63;56;0.98;33.62;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3)"
447;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X, 22122710;0.353;Q3;29;15;69;1119;77;65;0.96;74.6;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Drug Discovery (Q3); Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3)"
448;17500155003;Records of Natural Products;journal;13076167;0.349;Q3;33;67;227;1896;246;226;0.98;28.3;Turkey;Middle East;ACG Publications;2009-2022;"Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Plant Science (Q3)"
449;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.348;Q2;33;37;92;1568;187;90;1.68;42.38;Spain;Western Europe;Elsevier Espana;2005-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q3)"
450;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.346;Q2;42;338;831;6580;769;831;0.89;19.47;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2021;Pharmaceutical Science (Q2)
451;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.345;Q3;39;86;129;2889;181;129;1.2;33.59;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
452;21100853016;Antibodies;journal;20734468;0.341;Q3;15;21;24;2063;32;24;1.33;98.24;Switzerland;Western Europe;MDPI AG;2017-2021;"Drug Discovery (Q3); Immunology and Allergy (Q3); Immunology (Q4)"
453;23412;Journal of AOAC International;journal;10603271;0.338;Q3;90;199;684;5546;706;671;0.95;27.87;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q3); Environmental Chemistry (Q3); Food Science (Q3); Pharmacology (Q3)"
454;19700201609;Open Natural Products Journal;journal;18748481;0.338;Q3;3;0;4;0;4;4;0;0;Netherlands;Western Europe;;;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
455;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.334;Q3;38;54;158;2341;158;157;0.96;43.35;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q4)"
456;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.332;Q4;48;55;108;1702;183;98;1.84;30.95;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Biochemistry (Q4); Toxicology (Q4)"
457;21100202909;Drug Invention Today (discontinued);journal;09757619;0.33;Q3;20;1;60;11;126;59;0.4;11;India;Asiatic Region;Association of Pharmaceutical Innovators;2012-2021;Drug Discovery (Q3)
458;144879;Toxicology International;journal;09716580;0.329;Q4;28;48;183;1172;142;175;0.63;24.42;India;Asiatic Region;Society of Toxicology India;2005-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q4)"
459;11500153306;Recent Patents on Drug Delivery and Formulation;journal;22124039, 18722113;0.327;Q2;36;22;70;1540;89;66;1.33;70;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3)"
460;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.323;Q2;46;55;184;1551;242;182;1.03;28.2;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q2)
461;21100833039;Journal of HerbMed Pharmacology;journal;23455004;0.322;Q3;13;32;31;880;56;31;1.81;27.5;Iran;Middle East;Nickan Research Institute;2015-2021;Drug Discovery (Q3)
462;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.322;Q2;46;102;398;2038;190;361;0.67;19.98;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3); Public Health, Environmental and Occupational Health (Q3)"
463;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.319;Q3;26;160;330;3825;239;317;0.74;23.91;Bangladesh;Asiatic Region;Bangladesh Pharmacological Society;2009-2021;Pharmacology (Q3)
464;18800156720;Dissolution Technologies;journal;1521298X;0.319;Q2;34;24;99;392;63;69;0.59;16.33;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q2)
465;23489;Chemical Speciation and Bioavailability;journal;09542299;0.316;Q4;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q4)"
466;17700155034;Natural Product Communications;journal;15559475, 1934578X;0.314;Q3;50;459;1448;11650;1384;1418;0.87;25.38;United States;Northern America;SAGE Publications Inc.;2006-2022;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Plant Science (Q3)"
467;130038;Letters in Drug Design and Discovery;journal;15701808;0.313;Q2;35;134;368;4847;384;365;1.23;36.17;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
468;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;0.306;Q2;42;105;466;2608;450;439;0.82;24.84;India;Asiatic Region;Wolters Kluwer Medknow Publications;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Bioengineering (Q3)"
469;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.305;Q2;12;6;27;162;24;25;0.54;27;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
470;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.301;Q3;66;97;281;3741;274;253;0.91;38.57;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3)"
471;19900192163;Results in Pharma Sciences;journal;22112863;0.295;Q2;16;3;10;82;15;10;1.57;27.33;Netherlands;Western Europe;Elsevier BV;2011-2016;Pharmaceutical Science (Q2)
472;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.293;Q3;53;62;193;1328;140;176;0.59;21.42;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
473;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.293;Q2;19;45;87;1301;109;84;1.4;28.91;Iran;Middle East;Tabriz University of Medical Sciences;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
474;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0.292;Q2;21;42;102;1475;73;93;0.69;35.12;United Kingdom;Western Europe;BioMed Central Ltd.;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3)"
475;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;0.29;Q2;41;368;957;11806;790;954;0.8;32.08;India;Asiatic Region;MediPoeia;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
476;21100470510;Drug Research;journal;21949379, 21949387;0.289;Q3;65;98;413;2642;348;403;0.85;26.96;Germany;Western Europe;Thieme;1972, 2013-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
477;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996, 15969827;0.289;Q2;39;355;762;8657;684;761;0.72;24.39;Nigeria;Africa;Pharmacotherapy Group;2009-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q3)"
478;4700152608;African Journal of Traditional, Complementary and Alternative Medicines (discontinued);journal;25050044, 01896016;0.286;Q3;48;163;441;6113;463;440;0.8;37.5;Nigeria;Africa;African Ethnomedicines Network;2006-2017;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
479;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;0.286;Q4;7;30;79;386;10;70;0.12;12.87;India;Asiatic Region;Punjab Academy of Forensic Medicine and Toxicology;2011-2020;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
480;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.283;Q2;51;115;679;3813;500;676;0.77;33.16;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Clinical Biochemistry (Q3); Biochemistry (Q4)"
481;19700174904;Asian Journal of Pharmaceutical and Clinical Research (discontinued);journal;09742441, 24553891;0.282;Q2;41;670;1275;18046;765;1273;0.45;26.93;India;Asiatic Region;Asian Journal of Pharmaceutical and Clinical Research;2009-2018, 2020-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
482;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences (discontinued);journal;09751491;0.281;Q2;49;798;3661;25287;2339;3647;0.57;31.69;India;Asiatic Region;IJPPS;2009-2017, 2020-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
483;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.277;Q3;31;34;134;1503;145;119;0.79;44.21;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
484;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.276;Q3;29;75;369;2656;195;360;0.41;35.41;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
485;21810;Farmacia;journal;00148237;0.275;Q2;27;149;391;4051;449;391;1.37;27.19;Romania;Eastern Europe;Romanian Society for Pharmaceutical Sciences;1945-1946, 1973-1987, 2003, 2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
486;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.274;Q3;41;66;110;7763;119;14;1.17;117.62;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q3); Organic Chemistry (Q4)"
487;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.273;Q3;38;25;51;567;46;51;0.68;22.68;United States;Northern America;Old City Publishing;1996, 2002-2020;"Drug Discovery (Q3); Pharmacology (Q3); Cancer Research (Q4)"
488;4700152612;Current Nanoscience;journal;15734137;0.272;Q2;47;105;368;4903;397;353;1.02;46.7;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3); Nanoscience and Nanotechnology (Q3)"
489;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0.271;Q2;16;36;102;1018;64;90;0.54;28.28;United Kingdom;Western Europe;Oxford University Press;2010-2021;"Economics, Econometrics and Finance (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
490;21100285419;Expert Opinion on Orphan Drugs;journal;21678707;0.268;Q2;22;129;354;9882;203;350;0.56;76.6;United Kingdom;Western Europe;Taylor and Francis Ltd.;2013-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3); Pharmacology (medical) (Q3)"
491;21496;Revista de Chimie (discontinued);journal;00347752;0.268;-;31;559;997;13220;1167;997;1.29;23.65;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
492;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.267;Q3;24;25;76;1341;73;67;0.96;53.64;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)"
493;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.267;Q3;57;252;181;11252;253;180;1.39;44.65;United States;Northern America;Informa Healthcare;2013-2021;"Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
494;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.265;Q2;43;83;301;3008;238;291;0.57;36.24;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
495;19700175096;Pharmacognosy Journal;journal;09753575;0.265;Q3;25;96;217;3199;117;208;0.37;33.32;India;Asiatic Region;EManuscript Technologies;2009-2021;"Drug Discovery (Q3); Pharmacology (Q3)"
496;19700181240;Global Journal of Pharmacology (discontinued);journal;19920075;0.264;Q2;18;0;65;0;48;65;0.73;0;Pakistan;Asiatic Region;International Digital Organization for Scientific Information;2010-2014;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
497;19700174893;Dhaka University Journal of Pharmaceutical Sciences (discontinued);journal;18161839, 18161820;0.263;Q3;13;34;92;605;39;91;0.4;17.79;Bangladesh;Asiatic Region;University of Dhaka;2007-2018, 2020;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
498;110097;Food and Drug Law Journal;journal;1064590X;0.263;Q3;22;21;75;1282;53;73;0.8;61.05;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3)"
499;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.262;Q3;27;48;147;1801;99;138;0.65;37.52;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
500;3900148201;International Journal of Pharmacology (discontinued);journal;18125700, 18117775;0.258;Q3;39;97;227;4279;201;227;0.88;44.11;Pakistan;Asiatic Region;Asian Network for Scientific Information;2006-2018, 2020-2021;Pharmacology (Q3)
501;21100818733;Archives of Pharmacy Practice;journal;2045080X;0.252;Q3;2;5;1;116;2;1;2;23.2;India;Asiatic Region;Wolters Kluwer Medknow Publications;2014, 2016;Pharmaceutical Science (Q3)
502;5100152606;Biosciences Biotechnology Research Asia (discontinued);journal;09731245;0.251;Q3;18;241;1008;5948;402;1008;0.43;24.68;India;Asiatic Region;Oriental Scientific Publishing Company;2005-2016;"Agronomy and Crop Science (Q3); Biotechnology (Q3); Drug Discovery (Q3)"
503;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.25;Q2;24;109;207;2640;89;207;0.51;24.22;India;Asiatic Region;Rasayan Journal;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Biochemistry (Q4)"
504;19700177128;Journal of Young Pharmacists (discontinued);journal;09751505, 09751483;0.248;Q2;30;89;154;2059;121;143;0.5;23.13;India;Asiatic Region;EManuscript Services;2010-2018, 2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
505;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.247;Q3;10;10;39;631;19;0;0.38;63.1;United States;Northern America;Academic Press Inc.;2004-2005, 2008, 2012-2017, 2019;"Drug Discovery (Q3); Organic Chemistry (Q4)"
506;130089;Toxin Reviews;journal;15569543, 15569551;0.246;Q4;46;35;73;1543;75;71;1;44.09;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q4)
507;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.245;Q3;25;12;49;445;32;49;0.76;37.08;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmacology (nursing) (Q2); Pharmaceutical Science (Q3); Sports Science (Q4)"
508;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.242;Q3;22;41;161;1483;90;160;0.46;36.17;Chile;Latin America;MS-Editions;2008-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q3); Pharmacology (Q3); Plant Science (Q3)"
509;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.242;Q3;25;66;121;2201;110;115;0.88;33.35;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q3); Biochemistry (Q4); Biophysics (Q4); Molecular Medicine (Q4)"
510;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.242;Q4;48;11;63;2385;28;41;0.22;216.82;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Cancer Research (Q4); Toxicology (Q4)"
511;21100853513;Pharmaceutical Nanotechnology;journal;22117385, 22117393;0.241;Q3;13;1;10;13;10;10;1;13;Netherlands;Western Europe;Bentham Science Publishers B.V.;2014-2021;"Biomedical Engineering (Q3); Pharmaceutical Science (Q3)"
512;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.238;Q2;17;25;78;774;51;68;0.64;30.96;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
513;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.237;Q4;12;120;321;1626;43;321;0.13;13.55;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Law (Q3); Pathology and Forensic Medicine (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
514;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.236;Q3;21;6;30;995;45;0;1.39;165.83;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
515;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0.235;Q3;29;47;144;1292;110;115;0.78;27.49;Netherlands;Western Europe;Wolters Kluwer Medknow Publications;2010-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q3)"
516;21100244805;Journal of Vaccines and Vaccination (discontinued);journal;21577560;0.235;Q3;12;0;91;0;41;82;0.48;0;United States;Northern America;OMICS Publishing Group;2010-2014;"Drug Discovery (Q3); Immunology (Q4); Immunology and Allergy (Q4); Virology (Q4)"
517;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.231;Q3;29;0;22;0;12;20;0;0;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
518;21100366771;Journal of Applied Research on Medicinal and Aromatic Plants;journal;22147861;0.231;Q3;24;30;50;1274;55;49;1.1;42.47;Germany;Western Europe;Elsevier GmbH;2014-2021;"Drug Discovery (Q3); Plant Science (Q3)"
519;19700174961;BioProcess International;trade journal;15426319;0.23;Q3;23;67;411;576;118;406;0.21;8.6;United States;Northern America;PJB Publications Ltd.;2009-2017;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Drug Discovery (Q3)"
520;19700200880;Botulinum Journal;journal;17547326, 17547318;0.23;Q3;6;6;4;302;2;3;0;50.33;Switzerland;Western Europe;Inderscience Publishers;2009-2013, 2016;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Cellular and Molecular Neuroscience (Q4)"
521;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.227;Q3;24;68;239;1217;101;181;0.44;17.9;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
522;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.226;Q4;61;42;210;1565;116;164;0.69;37.26;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medical Laboratory Technology (Q3); Medicine (miscellaneous) (Q3); Toxicology (Q4)"
523;21100804474;European Pharmaceutical Journal;journal;24536725;0.224;Q3;8;15;66;256;20;63;0.43;17.07;Germany;Western Europe;de Gruyter;2016-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
524;11900154394;Oriental Journal of Chemistry (discontinued);journal;0970020X, 22315039;0.222;Q3;27;358;875;10359;576;875;0.7;28.94;India;Asiatic Region;Bhopal, S.A. Iqbal;1989, 2008-2018, 2021;"Chemistry (miscellaneous) (Q3); Drug Discovery (Q3); Biochemistry (Q4); Environmental Chemistry (Q4)"
525;13718;Pharmaceutical Engineering;journal;02738139;0.221;Q3;16;113;182;486;35;151;0.16;4.3;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
526;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences (discontinued);journal;09758585;0.221;Q3;31;2234;3521;49259;1403;3521;0.43;22.05;India;Asiatic Region;RJPBCS;2010-2017, 2020-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
527;21100426011;Nano LIFE;journal;17939844;0.217;Q3;1;0;1;0;1;1;1;0;Singapore;Asiatic Region;;;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Bioengineering (Q4); Biomedical Engineering (Q4)"
528;80593;Journal of Medicinal Plants;journal;16840240;0.216;Q3;23;58;156;2128;90;156;0.49;36.69;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
529;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.215;Q4;14;18;77;712;50;74;0.52;39.56;United Kingdom;Western Europe;Inderscience Enterprises Ltd;2008-2021;"Computer Science Applications (Q3); Drug Discovery (Q4)"
530;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.214;Q3;22;121;159;3431;79;158;0.47;28.36;India;Asiatic Region;Association of Pharmaceutical Teachers of India;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
531;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.213;Q3;34;159;478;3818;214;478;0.44;24.01;United States;Northern America;Springer New York;1967-2021;"Pharmacology (Q3); Drug Discovery (Q4)"
532;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0.212;Q3;10;9;25;551;11;25;0.25;61.22;New Zealand;Pacific Region;Libertas Academica Ltd.;2010-2018;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3)"
533;19446;American Pharmaceutical Review;journal;10998012;0.209;Q3;24;128;202;978;71;193;0.27;7.64;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q3)
534;21100205709;International Journal of Toxicological and Pharmacological Research (discontinued);journal;09755160;0.207;Q3;10;71;94;2230;56;94;0.54;31.41;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011-2016;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
535;21100220486;Journal of Pharmaceutical Investigation;journal;20935552, 20936214;0.207;Q3;31;59;161;2844;175;160;0.94;48.2;Netherlands;Western Europe;Springer Netherlands;2012-2021;"Pharmaceutical Science (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
536;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.205;Q3;19;30;61;865;35;48;0.6;28.83;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
537;19700181241;Physiology and Pharmacology;journal;17350581;0.205;Q3;12;34;124;1396;43;123;0.35;41.06;Iran;Middle East;Neuroscience Research Center;2009-2021;"Pharmacology (Q3); Physiology (Q4)"
538;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.204;Q3;29;29;105;890;51;105;0.49;30.69;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
539;20400195018;International Journal of Pharmacognosy and Phytochemical Research (discontinued);journal;09754873;0.203;Q4;19;302;475;9489;216;475;0.47;31.42;India;Asiatic Region;International Journal of Pharmacognosy and Phytochemical Research;2011-2016, 2020;Drug Discovery (Q4)
540;21100853564;AAPS Advances in the Pharmaceutical Sciences Series;book series;22107371, 2210738X;0.201;Q3;13;89;232;5980;69;227;0.3;67.19;Germany;Western Europe;Springer Verlag;2011, 2014-2021;Pharmaceutical Science (Q3)
541;22338;Hospital Pharmacy;journal;19451253, 00185787;0.201;Q3;24;148;448;2356;216;400;0.39;15.92;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacy (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
542;22881;Yaoxue Xuebao;journal;05134870;0.199;Q3;34;271;786;7355;439;786;0.56;27.14;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
543;21100195303;Eurasian Journal of Analytical Chemistry (discontinued);journal;13063057;0.198;Q3;16;23;35;620;23;35;0.63;26.96;Turkey;Middle East;Moment Publications;2010-2018, 2020;"Pharmaceutical Science (Q3); Analytical Chemistry (Q4); Electrochemistry (Q4); Spectroscopy (Q4)"
544;23171;Korean Journal of Pharmacognosy;journal;02533073;0.198;Q3;17;45;152;1128;39;152;0.26;25.07;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
545;19700188484;Journal of Bioequivalence and Bioavailability (discontinued);journal;09750851;0.197;Q3;12;0;85;0;44;64;0.7;0;United States;Northern America;OMICS Publishing Group;2011-2014;Pharmaceutical Science (Q3)
546;19700201333;International Journal of Drug Delivery (discontinued);journal;09750215;0.196;Q3;15;0;95;0;48;95;0.29;0;United States;Northern America;Advanced Research Journals;2011-2015;Pharmaceutical Science (Q3)
547;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0.196;Q4;10;1;16;137;7;16;0.5;137;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010-2016, 2018;"Biochemistry (Q4); Biophysics (Q4); Cell Biology (Q4); Pharmacology (Q4)"
548;19700188319;International Journal of Pharmaceutical Sciences Review and Research (discontinued);journal;0976044X;0.195;Q3;33;627;1783;16789;716;1783;0.35;26.78;India;Asiatic Region;Global Research Online;2010-2016, 2020-2021;Pharmaceutical Science (Q3)
549;79053;Natural Product Sciences;journal;12263907;0.195;Q4;28;49;154;1163;65;153;0.49;23.73;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
550;5800173401;Current Bioactive Compounds;journal;15734072;0.194;Q3;27;46;94;1662;52;85;0.46;36.13;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
551;21100226424;Toxicology and Environmental Health Sciences;journal;20059752, 22337784;0.194;Q4;17;41;103;1698;60;103;0.69;41.41;South Korea;Asiatic Region;Korean Society of Environmental Risk Assessment and Health Science;2009-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
552;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.191;Q3;48;89;331;3054;171;330;0.43;34.31;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Organic Chemistry (Q4)"
553;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.191;Q4;22;20;60;744;30;60;0.35;37.2;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q4)
554;17700156303;Neuromethods;book series;19406045, 08932336;0.191;Q3;21;247;551;13565;141;491;0.26;54.92;United States;Northern America;Humana Press;2009-2022;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4); Psychiatry and Mental Health (Q4)"
555;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.191;Q4;19;14;44;216;16;44;0.41;15.43;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Pharmacy (Q2); Drug Guides (Q3); Pharmacology (Q4)"
556;5400152620;American Journal of Pharmacology and Toxicology (discontinued);journal;15574970, 15574962;0.189;Q3;21;4;59;172;41;56;0.53;43;United States;Northern America;Science Publications;2007-2016;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
557;21100440523;Interaction Design and Architecture(s);journal;18269745, 22832998;0.189;Q4;14;39;96;1394;78;92;0.83;35.74;Italy;Western Europe;ASLERD;2012-2021;"Architecture (Q2); Media Technology (Q2); Social Sciences (miscellaneous) (Q3); Computer Science Applications (Q4); Human-Computer Interaction (Q4); Pharmacology (Q4)"
558;19408;Actualites Pharmaceutiques;journal;05153700;0.188;Q4;5;171;511;1032;25;401;0.05;6.04;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
559;19700174900;International Journal of Green Pharmacy (discontinued);journal;19984103, 09738258;0.188;Q3;26;75;160;2647;89;160;0.42;35.29;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
560;21100456601;Journal of Pharmacy and Pharmacognosy Research;journal;07194250;0.188;Q3;10;24;47;855;24;45;0.57;35.63;Chile;Latin America;Asociacion Academica de Ciencias Farmaceuticas de Antofagasta (ASOCIFA);2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
561;58808;Pharmaceutical Care and Research;journal;16712838;0.187;Q3;8;119;474;1152;25;471;0.07;9.68;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
562;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.187;Q3;9;30;104;377;10;84;0.11;12.57;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (Q4)"
563;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.186;Q3;4;55;179;1292;10;170;0.07;23.49;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
564;21100201517;RSC Drug Discovery Series;book series;20413203, 20413211;0.183;Q4;10;104;139;12446;44;127;0.32;119.67;United Kingdom;Western Europe;Royal Society of Chemistry;2010, 2014-2021;Drug Discovery (Q4)
565;21100293201;International Journal of Research in Ayurveda and Pharmacy (discontinued);journal;22774343, 22293566;0.182;Q3;13;23;329;603;91;329;0.23;26.22;India;Asiatic Region;Moksha Publishing House;2012-2016;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
566;20065;BioPharm International;trade journal;1542166X, 19391862;0.181;Q3;29;132;367;983;81;309;0.23;7.45;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q3); Biotechnology (Q4)"
567;19700188309;Journal of Bioanalysis and Biomedicine (discontinued);journal;1948593X;0.18;Q3;11;0;41;0;21;26;0;0;United States;Northern America;OMICS Publishing Group;2010-2014;Pharmaceutical Science (Q3)
568;21211;Pharmacy Education;journal;14772701, 15602214;0.18;Q3;18;33;85;507;21;85;0.25;15.36;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Education (Q4)"
569;5800179590;Pharmacologyonline (discontinued);journal;18278620;0.178;Q4;27;91;203;2707;79;203;0.43;29.75;Italy;Western Europe;SILAE - Societa Italo-Latinoamericana di Etnomedicina;2007-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
570;19700174978;American Journal of Pharmacy Benefits;journal;21642494, 19454481;0.177;Q3;15;33;160;711;36;130;0.15;21.55;United States;Northern America;Managed Care and Healthcare Communications;2010-2018;"Business and International Management (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Decision Sciences (miscellaneous) (Q4)"
571;21100455613;International Conference on Environmental Pollution and Public Health, EPPH 2015;conference and proceedings;-;0.176;-;5;0;15;0;9;14;0.6;0;China;Asiatic Region;;;Software
572;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.172;Q4;17;49;112;1387;43;99;0.39;28.31;Iran;Middle East;Shahid Beheshti University of Medical Sciences;2012-2021;"Cardiology and Cardiovascular Medicine (Q3); Critical Care and Intensive Care Medicine (Q3); Infectious Diseases (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
573;19700174931;Asian Journal of Pharmaceutics (discontinued);journal;1998409X, 09738398;0.172;Q3;23;138;110;3966;51;109;0.42;28.74;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
574;21758;Prescrire International;journal;11677422;0.171;Q4;13;139;614;1151;92;560;0.17;8.28;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
575;4700152607;Current Enzyme Inhibition;journal;15734080;0.17;Q4;18;23;51;1435;17;44;0.33;62.39;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
576;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0.169;Q3;13;32;63;810;30;62;0.23;25.31;Iran;Middle East;Iranian Association of Pharmaceutical Scientists;2010-2014, 2016-2021;"Pharmaceutical Science (Q3); Bioengineering (Q4)"
577;21100376682;Toxicologie Analytique et Clinique;journal;23520078;0.168;Q4;9;47;106;1169;24;95;0.2;24.87;France;Western Europe;Elsevier Masson s.r.l.;2014-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
578;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.168;Q3;43;223;547;4404;182;456;0.35;19.75;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
579;19700200860;International Journal of Current Pharmaceutical Review and Research (discontinued);journal;0976822X;0.167;Q3;14;115;64;3567;25;64;0.33;31.02;India;Asiatic Region;Publishers, In-IJCPR;2010-2017;Pharmaceutical Science (Q3)
580;21100301603;National Journal of Physiology, Pharmacy and Pharmacology (discontinued);journal;23204672, 22313206;0.167;Q3;13;126;192;2935;54;182;0.25;23.29;India;Asiatic Region;Mrs Dipika Charan for MedScience Publishers;2011-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Physiology (Q4)"
581;13000154717;Current Topics in Toxicology;journal;09728228;0.166;Q4;7;11;21;518;8;21;0.15;47.09;India;Asiatic Region;Research Trends;2007-2009, 2011-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
582;15600154705;EnvironmentAsia;journal;19061714;0.166;Q4;19;30;88;810;35;88;0.37;27;Thailand;Asiatic Region;Thai Society of Higher Eduation Institutes on Environment;2009-2021;"Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
583;5800173394;Current Drug Therapy;journal;15748855;0.165;Q3;17;14;70;572;30;64;0.37;40.86;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
584;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.164;Q3;6;51;143;105;14;125;0.12;2.06;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Pharmaceutical Science (Q3); Health Policy (Q4)"
585;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.164;Q3;9;46;190;1101;20;179;0.08;23.93;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3); Pharmacology (Q4)"
586;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.162;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
587;21100781436;Journal of Experimental Pharmacology;journal;11791454;0.162;Q4;15;8;6;369;8;6;0.8;46.13;New Zealand;Pacific Region;Dove Medical Press Ltd.;2010, 2012-2021;"Pharmacology (medical) (Q3); Molecular Medicine (Q4); Pharmacology (Q4)"
588;15842;Journal of Applied Research;journal;1537064X;0.161;Q4;22;0;6;0;1;6;0;0;United States;Northern America;The Journal of Applied Research;2001-2014;"Pharmacology (medical) (Q3); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
589;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.16;Q4;21;5;18;158;12;17;0.82;31.6;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q4)
590;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.16;Q4;14;45;151;1313;42;144;0.17;29.18;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
591;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.159;Q3;32;740;2649;3713;826;2649;0.27;5.02;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
592;19700175778;International Journal of Research in Pharmaceutical Sciences (discontinued);journal;09757538;0.158;Q3;21;44;199;1029;55;199;0.17;23.39;India;Asiatic Region;"JK Welfare &amp; Pharmascope Foundation";2010-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
593;19700174933;Journal of Pharmaceutical Sciences and Research (discontinued);journal;09751459;0.158;Q3;30;254;444;5871;147;444;0.25;23.11;India;Asiatic Region;;2009-2018, 2020-2021;Pharmaceutical Science (Q3)
594;22908;Chinese Pharmacological Bulletin;journal;10011978;0.157;Q4;17;327;1183;6114;482;1182;0.46;18.7;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q4)
595;19700173109;Contract Pharma;trade journal;15443469, 23806559;0.157;Q3;4;125;381;248;18;369;0.06;1.98;United States;Northern America;Contract Pharma;2009-2018;"Industrial Relations (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
596;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.157;Q3;16;39;115;1223;40;115;0.3;31.36;Turkey;Middle East;Turkish Pharmacists  Association;2006-2021;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
597;19700200724;Der Pharmacia Lettre (discontinued);journal;09755071;0.155;Q3;28;790;1101;23089;647;1101;0.59;29.23;India;Asiatic Region;Scholars Research Library;2011-2016;Pharmaceutical Science (Q3)
598;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0.155;Q4;7;4;13;102;8;13;0.38;25.5;India;Asiatic Region;Medicinal and Aromatic Plants Association of India;2010-2019;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
599;22934;Chinese Pharmaceutical Journal;journal;10012494;0.154;Q3;21;400;1341;7316;281;1341;0.22;18.29;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
600;21100446418;Contemporary Clinical Trials Communications;journal;24518654;0.154;Q4;17;70;9;2175;2;7;0.22;31.07;United States;Northern America;Elsevier Inc.;2015-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
601;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.153;Q4;14;19;70;965;21;62;0.23;50.79;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
602;19700201521;Journal of Chemical and Pharmaceutical Research (discontinued);journal;09757384;0.153;Q3;39;104;3193;3108;1214;3192;0.36;29.88;India;Asiatic Region;JOCPR;2004, 2011-2016;Pharmaceutical Science (Q3)
603;130170;Phytotherapie;journal;17652847, 16248597;0.153;Q4;18;76;232;2153;38;179;0.15;28.33;France;Western Europe;Springer Paris;2005-2020;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
604;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.153;Q4;14;24;65;151;20;65;0.25;6.29;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
605;15500154707;International Journal of Biological Chemistry (discontinued);journal;21522561, 1819155X;0.152;Q4;16;1;44;20;14;44;0.28;20;Pakistan;Asiatic Region;Asian Network for Scientific Information;2009-2016;"Biochemistry (Q4); Pharmacology (Q4)"
606;19700188355;International Journal of Phytomedicine (discontinued);journal;09750185;0.152;Q4;20;63;174;2205;55;174;0.2;35;United States;Northern America;Advanced Research Journals;2010-2016;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
607;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.151;Q4;24;20;58;746;28;52;0.47;37.3;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Infectious Diseases (Q4); Pharmacology (Q4)"
608;21100228007;Archives of Razi Institute;journal;20089872, 03653439;0.15;Q4;10;31;86;946;30;86;0.29;30.52;Iran;Middle East;Razi Vaccine and Serum Research Institute;2012-2021;"Immunology and Microbiology (miscellaneous)  (Q4); Toxicology (Q4); Veterinary (miscellaneous) (Q4)"
609;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.15;Q3;11;71;227;0;75;221;0.28;0;United States;Northern America;International Journal of Pharmaceutical Compounding;2006-2021;"Pharmacology (nursing) (Q2); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacy (Q3); Medicine (miscellaneous) (Q4)"
610;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;0.149;Q3;13;106;299;3266;89;293;0.29;30.81;China;Asiatic Region;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-2021;Pharmaceutical Science (Q3)
611;19700188326;American Journal of Drug Discovery and Development (discontinued);journal;2150427X, 21504296;0.148;Q4;12;0;58;0;20;58;0.52;0;United States;Northern America;Academic Journals Inc.;2011-2015;Drug Discovery (Q4)
612;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.148;-;12;32;97;745;23;97;0.28;23.28;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q4)
613;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.148;Q3;19;278;778;1682;19;750;0.02;6.05;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q3)
614;21100237602;Journal of Pharmacy and Nutrition Sciences (discontinued);journal;19275951, 22233806;0.146;Q3;12;25;82;928;17;82;0.25;37.12;Canada;Northern America;;2011-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health (social science) (Q4); Medicine (miscellaneous) (Q4); Nutrition and Dietetics (Q4)"
615;19700177006;Psychopharm Review;trade journal;19369255;0.146;Q4;4;0;14;0;3;14;0;0;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2009-2014;"Pharmacology (medical) (Q3); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
616;21100399725;Journal of Reports in Pharmaceutical Sciences;journal;23225106, 23221232;0.145;Q3;9;16;67;415;33;66;0.54;25.94;Iran;Middle East;Wolters Kluwer Medknow Publications;2012-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4); Pharmacology (medical) (Q4)"
617;20500195212;International Journal of Drug Delivery Technology;journal;09754415;0.144;Q3;10;19;23;642;8;23;0.35;33.79;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011-2012, 2014-2021;Pharmaceutical Science (Q3)
618;21100451405;Natural Products Journal;journal;22103163, 22103155;0.144;Q4;13;38;101;2030;34;96;0.32;53.42;Netherlands;Western Europe;Bentham Science Publishers B.V.;2011-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
619;73430;Pharmaceutical Technology;journal;15432521;0.144;Q3;38;208;465;893;58;435;0.15;4.29;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q3); Biophysics (Q4)"
620;22977;Journal de Pharmacie de Belgique;journal;00472166;0.143;Q3;12;0;81;0;16;75;0.26;0;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Pharmaceutical Science (Q3); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
621;19700174658;Regulatory Rapporteur;trade journal;17428955;0.143;Q3;6;68;212;467;11;148;0.06;6.87;United Kingdom;Western Europe;TOPRA;2010-2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacy (Q3)"
622;19700170837;Vitae;journal;21452660, 01214004;0.143;Q3;15;193;232;3166;24;87;0.09;16.4;Colombia;Latin America;Universidad de Antioquia;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4)"
623;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.142;Q4;14;35;90;841;17;90;0.11;24.03;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
624;73076;Drug Discovery World;journal;14694344;0.141;Q4;13;34;112;400;25;100;0.18;11.76;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
625;21100788832;International Journal of Medicinal Chemistry;journal;20902069, 20902077;0.141;Q4;4;3;3;106;1;3;0.33;35.33;United States;Northern America;Hindawi Publishing Corporation;2014-2016;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
626;21100242405;Marmara Pharmaceutical Journal;journal;13090801;0.14;Q3;0;0;0;0;0;0;0;0;Turkey;Middle East;Marmara University;2010-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
627;144613;Journal of Generic Medicines (discontinued);journal;17411343;0.139;Q3;15;0;79;0;12;68;0.09;0;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science (Q3)
628;17700155411;Research Journal of Environmental Toxicology (discontinued);journal;18193420;0.139;Q4;18;25;46;853;22;46;0.46;34.12;United States;Northern America;Academic Journals Inc.;2009-2016;"Health, Toxicology and Mutagenesis (Q4); Pollution (Q4); Toxicology (Q4)"
629;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0.138;Q3;6;12;34;242;9;33;0.18;20.17;India;Asiatic Region;Wolters Kluwer Medknow Publications;2010-2011, 2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
630;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0.138;Q4;10;41;133;1380;25;129;0.1;33.66;Netherlands;Western Europe;IOS Press BV;2010-2021;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
631;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.138;Q3;18;2;215;63;50;215;0.16;31.5;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q3)
632;20564;Ceska a Slovenska Farmacie;journal;12107816;0.137;Q3;17;28;110;487;36;106;0.44;17.39;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
633;19200156925;Cancer Therapy;journal;15439143, 15439135;0.135;Q4;8;0;13;0;3;13;0;0;United States;Northern America;Gene Therapy Press;2009-2014;"Cancer Research (Q4); Oncology (Q4); Pharmacology (Q4)"
634;19700174925;European Pharmaceutical Review;trade journal;13608606;0.135;Q3;8;59;189;734;26;185;0.13;12.44;United Kingdom;Western Europe;Russell Publishing LLC;2009-2019;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4)"
635;21100256959;Biomarkers and Genomic Medicine;journal;22140247;0.134;Q4;12;0;79;0;30;79;0.45;0;United States;Northern America;Elsevier BV;2013-2015;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)"
636;17600155051;Drug Development and Delivery;trade journal;1944818X, 15372898;0.134;Q3;11;70;251;254;25;104;0.1;3.63;United States;Northern America;Drug Delivery Technology;2009-2021;Pharmaceutical Science (Q3)
637;19900192173;International Journal of Pharmaceutical and Clinical Research (discontinued);journal;09751556;0.134;Q3;13;223;184;5953;50;184;0.29;26.7;Australia;Pacific Region;International Journal of Pharmaceutical and Clinical Research;2011-2016;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (medical) (Q4)"
638;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.133;Q4;10;40;218;835;44;218;0.21;20.88;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
639;25197;Revista de Toxicologia (discontinued);journal;02127113;0.133;Q4;11;18;55;658;9;51;0.18;36.56;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
640;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685, 19054637;0.133;Q3;12;75;143;1181;23;142;0.22;15.75;Thailand;Asiatic Region;Thai Journal of Pharmaceutical Sciences;2009-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
641;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.132;Q4;16;111;308;1378;32;308;0.1;12.41;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
642;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.132;Q4;13;38;122;786;18;120;0.13;20.68;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q4)
643;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.132;Q4;12;0;29;0;10;29;0;0;Japan;Asiatic Region;Medical and Pharmaceutical Society for WAKAN-YAKU;2004-2013;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
644;19700201140;Systematic Reviews in Pharmacy (discontinued);journal;09758453, 09762779;0.132;Q4;28;23;14;1099;3;14;0;47.78;India;Asiatic Region;EManuscript Technologies;2010-2021;Pharmaceutical Science (Q4)
645;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.131;Q4;17;716;1961;6636;332;1890;0.14;9.27;China;Asiatic Region;Editorial Office of Chinese Traditional and Herbal Drugs;2006-2021;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
646;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;0.13;Q3;7;18;30;265;8;30;0.11;14.72;India;Asiatic Region;Dr. Yashwant Research Labs Pvt. Ltd.;2011, 2013-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
647;19600162009;Advances in Molecular Toxicology;book series;18720854, 22122044;0.129;Q4;15;9;22;1428;7;0;0.33;158.67;Netherlands;Western Europe;Elsevier;2006, 2008-2018, 2020;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
648;19700182629;Methods in Pharmacology and Toxicology;book series;15572153, 19406053;0.129;Q3;10;67;124;6003;27;120;0.22;89.6;United States;Northern America;Humana Press;2008, 2012, 2014-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4); Pharmacology (medical) (Q4)"
649;21100196907;Open Toxinology Journal;journal;18754147;0.129;Q4;2;0;1;0;2;1;0;0;Netherlands;Western Europe;;;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (medical) (Q4); Toxicology (Q4)"
650;17300154738;Current Trends in Biotechnology and Pharmacy;journal;22307303, 09738916;0.128;Q4;14;42;128;1444;25;128;0.16;34.38;India;Asiatic Region;Association of Biotechnology and Pharmacy;2009-2021;"Biotechnology (Q4); Drug Discovery (Q4); Pharmaceutical Science (Q4)"
651;19700201471;International Journal of Pharmacy and Technology (discontinued);journal;0975766X;0.128;Q3;23;1939;437;32570;159;437;0.42;16.8;India;Asiatic Region;International Journal of Pharmacy and Technology(IJPT);2011-2016;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4)"
652;24097;Journal of the Indian Chemical Society;journal;00194522;0.128;Q4;33;162;881;5762;156;878;0.18;35.57;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
653;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.127;Q4;8;0;19;0;4;19;0.11;0;Egypt;Africa/Middle East;Faculty of Pharmacy, Assiut University;2008-2014, 2018-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
654;19700175758;International Journal of Drug Development and Research (discontinued);journal;09759344;0.127;Q4;24;0;320;0;71;319;0.22;0;India;Asiatic Region;International Journal of Drug Development and Research;2010-2015;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
655;19700174924;Biomedical and Pharmacology Journal;journal;09746242;0.126;Q4;22;172;550;3874;91;550;0.16;22.52;India;Asiatic Region;Oriental Scientific Publishing Company;2009-2021;Pharmacology (Q4)
656;9100153105;Current Topics in Pharmacology;journal;09724559;0.126;Q4;6;4;37;377;7;37;0.19;94.25;India;Asiatic Region;Research Trends;2006-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
657;21100398550;Orphan Drugs: Research and Reviews;journal;22306161;0.126;Q4;3;0;12;0;2;12;0.17;0;New Zealand;Pacific Region;Dove Medical Press Ltd.;2014-2015, 2017;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
658;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.125;Q4;11;13;71;460;12;71;0.13;35.38;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Clinical Psychology (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
659;19700175039;Open Toxicology Journal;journal;18743404;0.125;Q4;8;0;6;0;3;5;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2010, 2012-2013;Toxicology (Q4)
660;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.125;Q4;47;447;790;9079;95;788;0.12;20.31;India;Asiatic Region;A and V Publication;1997, 2005, 2011-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
661;22906;Journal of China Pharmaceutical University;journal;10005048;0.124;Q4;14;119;337;2553;55;337;0.17;21.45;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
662;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.124;Q4;5;32;114;777;12;98;0.08;24.28;Czech Republic;Eastern Europe;SOLEN S.R.O.;2009-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
663;21100784631;AIAA Modeling and Simulation Technologies Conference, 2015;conference and proceedings;-;0.123;-;0;0;1;0;0;1;0;0;United States;Northern America;;;"Bioengineering; Drug Discovery"
664;21100853531;Indian Journal of Novel Drug Delivery;journal;09755500;0.123;Q4;0;1;1;22;0;1;0;22;India;Asiatic Region;Karnataka Education and Scientific Society;2015-2016;Pharmaceutical Science (Q4)
665;21100790356;International Journal of Life Sciences Biotechnology and Pharma Research;journal;22503137;0.123;Q4;1;1;1;47;0;1;0;47;India;Asiatic Region;;2012, 2014, 2016;"Applied Microbiology and Biotechnology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
666;21100785531;International Journal of Medicinal and Aromatic Plants;journal;22494340;0.123;Q4;3;0;1;0;1;1;0;0;India;Asiatic Region;;;"Drug Discovery (Q4); Plant Science (Q4)"
667;21100205919;Open Drug Discovery Journal;journal;18773818;0.123;Q4;9;0;1;0;0;1;0;0;United Arab Emirates;Middle East;Bentham open;2010, 2014;Drug Discovery (Q4)
668;21142;Pharmaceutisch Weekblad;journal;00316911;0.123;Q4;9;334;1234;441;5;838;0.01;1.32;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
669;21100853008;Pharmacie Globale;journal;09768157;0.123;Q4;0;0;1;0;0;1;0;0;India;Asiatic Region;;;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
670;21100784233;Proceedings of the 2013 21st Euromicro International Conference on Parallel, Distributed, and Network-Based Processing, PDP 2013;conference and proceedings;-;0.123;-;0;0;1;0;0;1;0;0;United States;Northern America;;;"Pharmaceutical Science; Statistics and Probability"
671;19700174987;Research Journal of Toxins (discontinued);journal;18193560, 21517258;0.123;Q4;3;2;1;50;0;1;0;25;United States;Northern America;Academic Journals Inc.;2009, 2014, 2016;"Agronomy and Crop Science (Q4); Food Science (Q4); Toxicology (Q4)"
672;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.122;Q4;14;17;44;695;6;44;0.13;40.88;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
673;21265;Drugs of the Future;journal;03778282;0.122;Q4;45;83;338;2200;48;330;0.04;26.51;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
674;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.122;Q4;19;0;72;0;18;55;0.1;0;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Marketing (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Strategy and Management (Q4)"
675;21102;Pharmaceutical Journal;journal;00316873;0.122;Q4;28;276;727;915;34;197;0.05;3.32;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
676;21127;Pharmaceutical Technology Europe;journal;01646826;0.122;Q4;18;147;374;655;17;315;0.04;4.46;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q4)
677;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.121;Q4;21;0;27;0;6;27;0;0;Iran;Middle East;Academy of Medical Sciences of I.R. Iran;2006-2015;Pharmacology (Q4)
678;19700174940;SA Pharmaceutical Journal;journal;10151362;0.121;Q4;7;113;289;1099;23;210;0.07;9.73;South Africa;Africa;Medpharm Publications;2009-2021;Pharmaceutical Science (Q4)
679;21000195625;Asian Journal of Pharmaceutical Research and Health Care (discontinued);journal;22501444, 22501460;0.12;Q4;6;30;27;844;8;27;0.29;28.13;India;Asiatic Region;;2011-2016;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
680;22514;Japanese Journal of Chemotherapy;journal;13407007;0.12;Q4;12;21;61;304;8;61;0.13;14.48;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
681;11200153306;Journal of Pharmacology and Toxicology (discontinued);journal;1816496X, 2152100X;0.12;Q4;18;4;32;161;9;32;0.25;40.25;United States;Northern America;Academic Journals Inc.;2008-2017;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
682;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.12;Q4;9;12;17;325;4;16;0.24;27.08;Turkey;Middle East;University of Istanbul;2005, 2007-2008, 2010, 2012, 2015-2016;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
683;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.119;Q4;20;34;93;629;13;90;0.14;18.5;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q4); Pharmaceutical Science (Q4)"
684;21100265336;International Arabic Journal of Antimicrobial Agents (discontinued);journal;21749094;0.119;Q4;8;0;30;0;8;30;0.29;0;Spain;Western Europe;Internet Medical Publishing;2011-2015;"Microbiology (medical) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
685;19700201516;Journal of Chemical and Pharmaceutical Sciences (discontinued);journal;09742115;0.119;Q4;25;894;740;15727;186;740;0.23;17.59;India;Asiatic Region;SPB Pharma Society;2010-2016;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
686;19700175071;Open Bioactive Compounds Journal;journal;18748473;0.119;Q4;6;0;4;0;2;4;0;0;Netherlands;Western Europe;;;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
687;19700175149;African Journal Biomedical Research;journal;11195096;0.118;Q4;17;34;79;1097;17;79;0.14;32.26;Nigeria;Africa;Ibadan Biomedical Communications Group;2008, 2010-2021;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
688;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.118;Q4;19;15;79;872;24;73;0.24;58.13;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2018, 2020;"Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
689;19700175049;Internet Journal of Toxicology;journal;15593916;0.118;Q4;7;0;7;0;5;7;0;0;United States;Northern America;Internet Scientific Publications, LLC;2009-2011, 2013, 2015;Toxicology (Q4)
690;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.118;Q4;10;15;59;561;14;59;0.22;37.4;Jordan;Middle East;The University of Jordan;2009-2021;Pharmaceutical Science (Q4)
691;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.117;Q4;10;45;110;1850;18;96;0.23;41.11;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
692;19700174997;ONdrugDelivery;trade journal;2049145X, 20491468;0.117;Q4;6;106;171;491;25;104;0.18;4.63;United Kingdom;Western Europe;Frederick Furness Publishing;2009-2020;Pharmaceutical Science (Q4)
693;19900193894;Open Pharmacoeconomics and Health Economics Journal;journal;18768245;0.117;Q4;3;0;2;0;2;2;0;0;Netherlands;Western Europe;;;"Economics, Econometrics and Finance (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
694;21243;Pharmacy Times;trade journal;00030627;0.117;Q4;8;240;884;1054;18;265;0.02;4.39;United States;Northern America;Intellisphere LLC;1977-1987, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
695;19700174966;Pharmakeftiki;journal;22413081, 11054999;0.117;Q4;5;10;33;405;3;30;0.11;40.5;Greece;Western Europe;Zita Medical Managent;2008-2010, 2012-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
696;21100291830;Selenium in the Environment and Human Health - Proceedings of the 3rd International Conference on Selenium in the Environment and Human Health;conference and proceedings;-;0.117;-;5;0;92;0;18;90;0.2;0;Netherlands;Western Europe;;;"Health, Toxicology and Mutagenesis; Toxicology"
697;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.115;Q4;7;13;59;418;5;54;0.05;32.15;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q4)
698;21823;Pharmacia;journal;04280296;0.115;Q4;16;22;71;507;9;71;0.13;23.05;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
699;19700171709;Arhiv za Farmaciju;journal;00041963;0.114;Q4;4;20;91;732;6;86;0.06;36.6;Serbia;Eastern Europe;Farmaceutsko Drustvo Srbije;1954-1955, 2009-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
700;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.114;Q4;12;122;481;4796;55;429;0.1;39.31;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
701;22375;Indian Drugs;journal;0019462X;0.114;Q4;31;119;238;2161;20;238;0.08;18.16;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
702;5200152604;Pharma Times;journal;00316849;0.114;Q4;12;76;262;572;14;141;0.04;7.53;India;Asiatic Region;Indian Pharmaceutical Association;2006-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
703;5800207507;Side Effects of Drugs Annual;book series;03786080;0.114;Q4;6;49;157;2983;11;0;0.07;60.88;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
704;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.113;Q4;15;95;329;1075;42;329;0.11;11.32;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
705;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.113;Q4;19;120;362;2650;28;262;0.07;22.08;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
706;19700174922;Chinese Journal of New Drugs;journal;10033734;0.112;Q4;12;510;1691;6407;135;1691;0.08;12.56;China;Asiatic Region;Chinese Journal of New Drugs Co. Ltd.;2008-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
707;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.111;Q4;2;0;3;0;0;2;0;0;Germany;Western Europe;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
708;21798;Farmaceutski Glasnik;journal;00148202;0.111;Q4;6;76;220;827;3;177;0.02;10.88;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
709;21100241763;International Journal of Green Nanotechnology;journal;19430906, 19430892;0.111;Q4;4;0;11;0;6;10;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2014;"Biomedical Engineering (Q4); Chemistry (miscellaneous) (Q4); Electrical and Electronic Engineering (Q4); Materials Science (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
710;19700174645;International Journal of Pharmaceutical Research (discontinued);journal;09752366;0.111;Q4;24;47;155;1294;17;155;0.14;27.53;India;Asiatic Region;Advanced Scientific Research;2010-2021;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
711;19700201404;Open Drug Safety Journal;journal;18768180;0.111;Q4;3;0;2;0;0;2;0;0;Netherlands;Western Europe;;;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
712;19700175040;Open Vaccine Journal;journal;18750354;0.111;Q4;9;0;3;0;0;2;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Drug Discovery (Q4); Immunology (Q4); Pharmaceutical Science (Q4)"
713;20628;Circular Farmaceutica;journal;00097314;0.11;Q4;3;32;88;457;1;74;0.02;14.28;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
714;21100301409;Issues in Toxicology;book series;17577179, 17577187;0.11;Q4;16;76;133;6325;15;121;0.1;83.22;United Kingdom;Western Europe;Royal Society of Chemistry;2007-2021;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
715;21100782803;Current Psychopharmacology;journal;22115560, 22115579;0.109;Q4;4;16;4;1576;1;3;0.25;98.5;Netherlands;Western Europe;Bentham Science Publishers B.V.;2012, 2015-2016;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
716;21100199794;Industrial Pharmacy;trade journal;17414911;0.108;Q4;4;3;47;100;3;47;0.04;33.33;United Kingdom;Western Europe;Euromed Communications;2011-2016;Pharmaceutical Science (Q4)
717;19700175061;Open Pharmacology Journal;journal;18741436;0.108;Q4;6;0;4;0;0;3;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Drug Discovery (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
718;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.108;Q4;9;0;102;0;8;82;0.02;0;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
719;19700175108;Drug Delivery System;journal;18812732, 09135006;0.107;Q4;8;73;142;1010;8;99;0.05;13.84;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
720;19700175031;Research Journal of Pharmacology (discontinued);journal;19936019, 18159362;0.107;Q4;9;4;13;85;3;13;0.33;21.25;Pakistan;Asiatic Region;Medwell Publishing;2008-2014, 2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
721;22358;U.S. Pharmacist;trade journal;01484818;0.107;Q4;9;155;483;2746;26;375;0.04;17.72;United States;Northern America;Jobson Publishing Corporation;1979, 1990-1996, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
722;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.107;Q4;13;63;155;669;15;120;0.12;10.62;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
723;21100463816;39th International Precious Metals Conference: Charting Precious Metals through the Changing Currents of Compliance, Finance, Consumer Trends, Risk and New Technology, IPMI 2015;conference and proceedings;-;0.106;-;1;0;55;0;2;54;0.04;0;United States;Northern America;;;"Organic Chemistry; Pharmaceutical Science"
724;19700175137;Trends in Medical Research (discontinued);journal;18193587, 21516065;0.106;Q4;10;17;28;402;3;28;0.14;23.65;United States;Northern America;Academic Journals Inc.;2008-2016, 2020-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
725;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.105;Q4;7;5;18;217;4;18;0.17;43.4;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
726;21100853500;Clinical Cancer Drugs;journal;22126988, 2212697X;0.105;Q4;4;1;5;57;0;5;0;57;United Arab Emirates;Middle East;Bentham Science Publishers;2015-2016;"Cancer Research (Q4); Oncology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
727;19700200861;International Journal of Pharmaceutical Sciences;journal;09754725;0.105;Q4;11;0;5;0;0;5;0;0;India;Asiatic Region;R R College of Pharmacy;2010, 2012-2013;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
728;21100853545;Journal of Global Trends in Pharmaceutical Sciences;journal;22307346;0.105;Q4;1;4;5;86;0;5;0;21.5;India;Asiatic Region;Annamacharya College of Pharmacy;2015-2016;"Molecular Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
729;19700194018;Russian Journal of Biopharmaceuticals (discontinued);journal;20738099;0.105;Q4;6;45;126;761;11;125;0.09;16.91;Russian Federation;Eastern Europe;Folium Publishing Company;2011-2021;"Bioengineering (Q4); Drug Discovery (Q4)"
730;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.104;Q4;11;15;6;556;0;6;0;37.07;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
731;19700174886;Arzneimitteltherapie;journal;07236913;0.104;Q4;6;153;526;958;8;229;0.02;6.26;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;2008-2021;"Pharmacology (medical) (Q4); Pharmacology (nursing) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
732;25253;Blutalkohol (discontinued);journal;00065250;0.104;Q4;13;27;90;355;2;79;0.01;13.15;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
733;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.104;Q4;9;34;152;79;3;146;0.02;2.32;United Kingdom;Western Europe;Samedan Ltd;2007-2010, 2012-2019;Pharmaceutical Science (Q4)
734;21100853528;International Journal of Advances in Pharmaceutical Research;journal;22497226;0.104;Q4;0;0;6;0;0;6;0;0;India;Asiatic Region;;;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
735;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.104;Q4;7;82;672;1160;37;672;0.05;14.15;China;Asiatic Region;Jilin University Press;2005-2021;Pharmacology (Q4)
736;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.104;Q4;6;16;46;411;5;46;0.06;25.69;Switzerland;Western Europe;Springer Science + Business Media;2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
737;21100455612;2015 4th International Conference on Future Generation Communication Technology, FGCT 2015;conference and proceedings;-;0.103;-;5;0;29;0;14;27;0.48;0;United States;Northern America;;;"Health, Toxicology and Mutagenesis; Pollution; Toxicology"
738;21100456849;4th International Conference on Accelerating Biopharmaceutical Development 2015;conference and proceedings;-;0.103;-;0;0;8;0;0;7;0;0;United States;Northern America;;;"Chemistry (miscellaneous); Management of Technology and Innovation; Process Chemistry and Technology"
739;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.103;Q4;11;6;50;52;3;34;0.09;8.67;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
740;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.103;Q4;5;75;361;1868;17;342;0.03;24.91;China;Asiatic Region;Editorial office of Chinese Journal of Cancer Biotherapy;2008-2011, 2013-2016, 2018-2022;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
741;19700174992;European Journal of Oncology Pharmacy;journal;17833914;0.103;Q4;4;0;59;0;1;36;0.02;0;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2015, 2017-2019;"Oncology (Q4); Pharmacology (Q4)"
742;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277, 09644679;0.103;Q4;6;8;63;105;5;48;0.09;13.13;United Kingdom;Western Europe;Pharmaceutical and Healthcare Sciences Society;2010-2016, 2018-2021;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
743;21100853529;International Journal of Pharmaceutical and Phytopharmacological Research;journal;22501029;0.103;Q4;2;0;7;0;0;7;0;0;India;Asiatic Region;;;"Drug Discovery (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
744;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.103;Q4;7;33;174;404;3;163;0;12.24;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
745;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.103;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
746;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.103;Q4;3;36;165;29;2;163;0;0.81;United Kingdom;Western Europe;Samedan Ltd;2009-2016, 2018-2019;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
747;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.102;Q4;8;14;10;561;0;10;0;40.07;Venezuela;Latin America;Sociedad Latinoamericana de Hipertension;2007-2013, 2015-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
748;22887;Chinese Journal of Antibiotics;journal;10018689;0.102;Q4;11;0;458;0;14;458;0.03;0;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
749;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.102;Q4;5;124;398;1779;17;398;0.03;14.35;China;Asiatic Region;China Pharmaceutical University;2007-2021;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
750;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.102;Q4;5;11;86;476;1;80;0;43.27;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
751;21100407623;Multimedia Technology IV - Proceedings of the 4th International Conference on Multimedia Technology;conference and proceedings;-;0.102;-;1;0;28;0;2;27;0.07;0;Netherlands;Western Europe;;;"Health, Toxicology and Mutagenesis; Toxicology"
752;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.102;Q4;10;26;57;634;6;50;0.09;24.38;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
753;21100446017;Proceedings of the 16th International Association for Mathematical Geosciences - Geostatistical and Geospatial Approaches for the Characterization of Natural Resources in the Environment: Challenges, Processes and Strategies, IAMG 2014;conference and proceedings;-;0.102;-;2;0;148;0;4;146;0.03;0;India;Asiatic Region;;;"Organic Chemistry; Pharmaceutical Science"
754;21100456702;3rd International Conference on Accelerating Biopharmaceutical Development 2013;conference and proceedings;-;0.101;-;1;0;17;0;0;16;0;0;United States;Northern America;;;Safety, Risk, Reliability and Quality
755;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.101;Q4;6;0;34;0;0;34;0;0;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
756;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.101;Q4;18;4;26;205;0;26;0;51.25;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
757;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.101;Q4;3;0;18;0;1;15;0;0;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
758;21100202747;GMP Review;trade journal;14764547;0.101;Q4;2;0;27;0;1;27;0.09;0;United Kingdom;Western Europe;Euromed Communications Ltd;2011-2015, 2017-2021;Pharmaceutical Science (Q4)
759;19700200708;Journal of Global Pharma Technology (discontinued);journal;09758542;0.101;Q4;17;92;20;2491;1;20;0.13;27.08;India;Asiatic Region;Journal of Global Pharma Technology;2010-2020;Pharmaceutical Science (Q4)
760;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.101;Q4;5;10;25;155;2;25;0.12;15.5;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
761;21100348334;Pharmaceutical Discovery, Development and Manufacturing Forum 2013 - Core Programming Area at the 2013 AIChE Annual Meeting: Global Challenges for Engineering a Sustainable Future;conference and proceedings;-;0.101;-;1;0;74;0;2;72;0;0;United States;Northern America;;;"Organic Chemistry; Pharmaceutical Science"
762;21100463844;Pharmaceutical Discovery, Development and Manufacturing Forum 2015 - Core Programming Area at the 2015 AIChE Annual Meeting;conference and proceedings;-;0.101;-;0;0;21;0;0;20;0;0;United States;Northern America;;;"Energy (miscellaneous); Materials Science (miscellaneous); Pollution"
763;19700175034;Pharmaceutical Processing;trade journal;10499156;0.101;Q4;3;30;125;11;0;25;0;0.37;United States;Northern America;Advantage Business Media;2009-2018;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
764;19700175580;PharmacoVigilance Review;journal;17526752;0.101;Q4;2;8;32;22;0;26;0;2.75;United Kingdom;Western Europe;Euromed Communications;2010-2019;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
765;19700201509;Pharma Research (discontinued);journal;09758216;0.101;Q4;5;1;55;22;3;55;0.04;22;India;Asiatic Region;Sudarshan Publications;2011-2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
766;21100208082;VacciMonitor;journal;10250298, 1025028X;0.101;Q4;5;11;46;229;4;43;0;20.82;Cuba;Latin America;Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros;2012-2021;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Molecular Medicine (Q4)"
767;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.1;Q4;3;17;51;61;0;51;0;3.59;Azerbaijan;Eastern Europe;Azerbaijan Medical University;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
768;21238;Drug Topics;journal;19378157, 00126616;0.1;Q4;8;263;799;21;2;65;0;0.08;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
769;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.1;Q4;5;31;150;163;1;135;0;5.26;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
770;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.1;Q4;3;25;130;89;0;117;0;3.56;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
771;21100435458;Food, Pharmaceutical and Bioengineering Division 2015 - Core Programming Area at the 2015 AIChE Meeting;conference and proceedings;-;0.1;-;1;0;255;0;0;251;0;0;United States;Northern America;;;"Computer Networks and Communications; Computer Science Applications"
772;21867;Geneesmiddelenbulletin;journal;03044629;0.1;Q4;7;33;163;752;1;117;0;22.79;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
773;21100829925;HiSTOReLo;journal;2145132X;0.1;-;3;22;68;1029;6;56;0.07;46.77;Colombia;Latin America;Universidad Nacional de Colombia;2013-2021;History (Q4)
774;13637;Manufacturing Chemist;trade journal;02624230;0.1;Q4;6;27;245;83;1;215;0.01;3.07;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
775;19700201410;Milestones in Drug Therapy;book series;22966056;0.1;Q4;5;15;45;1560;0;43;0;104;United States;Northern America;Springer Science + Business Media;2010-2017;"Drug Discovery (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
776;21100446069;Pharmaceutical Discovery, Development and Manufacturing Forum 2014 - Core Programming Area at the 2014 AIChE Annual Meeting;conference and proceedings;-;0.1;-;1;0;53;0;0;52;0;0;United States;Northern America;;;Engineering (miscellaneous)
777;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;0.1;Q4;2;0;736;0;0;645;0;0;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
778;21716;Pharmazeutische Zeitung;journal;00317136;0.1;Q4;7;758;2227;481;6;1318;0;0.63;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
779;20572;PZ Prisma;journal;09455566;0.1;Q4;5;23;111;433;0;97;0;18.83;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
780;16800154712;Sp2;trade journal;1476184X;0.1;Q4;2;0;88;0;0;73;0;0;United Kingdom;Western Europe;Avakado Ltd;2009-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
781;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.1;Q4;10;0;69;0;0;67;0;0;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q4)
782;19900195040;Therapeutics, Pharmacology and Clinical Toxicology;journal;20660170, 15830012;0.1;Q4;3;10;53;271;0;52;0;27.1;Romania;Eastern Europe;Rp Publishing House;2011-2012, 2014-2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
783;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;;-;20;7;0;230;0;0;0;32.86;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science
784;21100841779;ADMET and DMPK;journal;18487718;;-;15;24;64;1184;48;59;0.7;49.33;Croatia;Eastern Europe;International Association of Physical Chemists;2013-2021;"Chemistry (miscellaneous); Health (social science); Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
785;21100853960;Anti-Tumor Pharmacy;journal;20951264;;-;2;24;20;679;2;20;0.1;28.29;China;Asiatic Region;;2014-2016;"Oncology; Pharmaceutical Science; Pharmacology (medical)"
786;21100854647;Applied In Vitro Toxicology;journal;23321512, 23321539;;-;12;1;1;54;0;1;0;54;United States;Northern America;Mary Ann Liebert Inc.;2015-2021;"Health, Toxicology and Mutagenesis; Medical Laboratory Technology; Toxicology"
787;21100854845;Asia Pacific Journal of Medical Toxicology;journal;23222611, 23224320;;-;0;2;0;47;0;0;0;23.5;Iran;Middle East;Mashhad University of Medical Sciences;2016;"Health, Toxicology and Mutagenesis; Toxicology"
788;21100892509;Cannabis and Cannabinoid Research;journal;23788763;;-;29;35;0;1457;0;0;0;41.63;United States;Northern America;Mary Ann Liebert Inc.;2016-2021;"Complementary and Alternative Medicine; Pharmacology; Pharmacology (medical)"
789;21101021640;Chinese Herbal Medicines;journal;16746384;;-;14;1;0;73;0;0;0;73;Netherlands;Western Europe;Elsevier BV;2012, 2016, 2018-2021;"Complementary and Alternative Medicine; Pharmacology; Pharmacology (medical)"
790;21100873055;Cosmetics;journal;20799284;;-;27;41;53;2373;55;50;1.04;57.88;Switzerland;Western Europe;MDPI AG;2014-2021;"Aging; Chemical Engineering (miscellaneous); Dermatology; Pharmaceutical Science; Surgery"
791;21100853871;Current Metabolomics;journal;22132368, 2213235X;;-;4;6;3;353;1;3;0.33;58.83;Netherlands;Western Europe;Bentham Science Publishers B.V.;2015-2016;"Analytical Chemistry; Biochemistry, Genetics and Molecular Biology (miscellaneous); Biochemistry (medical); Drug Discovery; Organic Chemistry"
792;21100804457;Current Opinion in Toxicology;journal;24682020;;-;27;18;0;1132;0;0;0;62.89;Netherlands;Western Europe;Elsevier BV;2016-2021;Toxicology
793;21101055116;Current Reviews in Clinical and Experimental Pharmacology;journal;27724328, 27724336;;-;43;35;134;2490;245;122;1.6;71.14;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
794;21100854828;Current Traditional Medicine;journal;22150846, 22150838;;-;4;3;1;111;5;1;5;37;Netherlands;Western Europe;Bentham Science Publishers B.V.;2015-2017, 2020-2021;"Complementary and Alternative Medicine; Drug Discovery"
795;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;25;94;1020;123;92;1.51;40.8;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
796;21100860941;Expert Review of Precision Medicine and Drug Development;journal;23808993;;-;12;52;0;4245;0;0;0;81.63;United Kingdom;Western Europe;Taylor and Francis Ltd.;2016-2021;"Drug Discovery; Genetics; Molecular Medicine; Pharmacology"
797;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;;-;7;10;31;493;7;31;0.16;49.3;Turkey;Middle East;Hacettepe University, Faculty of Pharmacy;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
798;21100867470;Indonesian Journal of Pharmacy;journal;23389486, 23389427;;-;7;31;0;832;0;0;0;26.84;Indonesia;Asiatic Region;Universitas Gadjah Mada - Faculty of Pharmacy;2016-2021;"Pharmaceutical Science; Pharmacology (medical); Pharmacy"
799;21100853873;International Journal of Current Pharmaceutical Research;journal;09757066;;-;5;4;7;117;7;7;1;29.25;India;Asiatic Region;Innovare Academic Sciences Pvt Ltd.;2014-2016;Pharmaceutical Science
800;21100785532;International Journal of Pharma Medicine and Biological Sciences;journal;22785221;;-;1;3;0;82;0;0;0;27.33;India;Asiatic Region;;2012, 2016;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
801;21100854889;Journal of Applied Pharmacy;journal;19204159;;-;2;6;0;254;0;0;0;42.33;Canada;Northern America;"Intellectual Consortium of Drug Discovery &amp; Technology Development Inc.";2016;"Pharmaceutical Science; Pharmacology"
802;21100902935;Journal of Biologically Active Products from Nature;journal;22311874, 22311866;;-;13;35;120;1318;56;120;0.48;37.66;United Kingdom;Western Europe;Taylor and Francis Ltd.;2011-2021;"Agricultural and Biological Sciences (miscellaneous); Complementary and Alternative Medicine; Drug Discovery; Pharmacology; Plant Science; Toxicology"
803;21101022494;Journal of Cardiovascular Development and Disease;journal;23083425;;-;21;33;37;3037;46;35;1.24;92.03;Switzerland;Western Europe;MDPI AG;2014-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
804;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;25;65;310;1;65;0.02;12.4;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
805;21100798510;Journal of Intercultural Ethnopharmacology (discontinued);journal;21468397;;-;18;65;0;2845;0;0;0;43.77;Turkey;Middle East;Ejmanager LLC;2016-2017;"Complementary and Alternative Medicine; Pharmacology; Pharmacology (medical); Toxicology"
806;21100881509;Journal of International Pharmaceutical Research;journal;16740440;;-;7;196;365;4335;32;365;0.06;22.12;China;Asiatic Region;Editorial office of Journal of International Pharmaceutical Research;2010-2011, 2013-2020;Pharmaceutical Science
807;21100854827;Journal of Nanopharmaceutics and Drug Delivery;journal;21679312, 21679320;;-;1;2;0;588;0;0;0;294;United States;Northern America;American Scientific Publishers;2016;"Biomedical Engineering; Medicine (miscellaneous); Pharmaceutical Science"
808;21100815317;Journal of Pharmacopuncture;journal;20936966, 22346856;;-;18;38;0;967;0;0;0;25.45;South Korea;Asiatic Region;Korean Pharmacopuncture Institute;2016-2021;"Complementary and Alternative Medicine; Pharmacology"
809;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;;-;6;6;6;230;0;6;0;38.33;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology
810;21100928216;Journal of Research in Pharmacy;journal;26306344;;-;16;52;89;1612;32;89;0.29;31;Turkey;Middle East;Marmara University;2019-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
811;21100853985;Journal of Xenobiotics;journal;20394705;;-;2;2;6;47;3;2;0.5;23.5;Italy;Western Europe;PagePress Publications;2014-2016;"Pharmacology; Pollution; Toxicology"
812;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;350;815;8401;289;807;0.35;24;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
813;21100924771;Natural Products and Bioprospecting;journal;21922209, 21922195;;-;26;34;118;1159;136;118;1.15;34.09;Singapore;Asiatic Region;Springer Singapore;2011-2021;"Analytical Chemistry; Biochemistry; Food Science; Organic Chemistry; Pharmacology; Plant Science; Toxicology"
814;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;14;1;12;0;0;12;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
815;21100875801;npj Systems Biology and Applications;journal;20567189;;-;25;19;9;1000;10;8;1.11;52.63;United Kingdom;Western Europe;Nature Publishing Group;2015-2021;"Applied Mathematics; Biochemistry, Genetics and Molecular Biology (miscellaneous); Computer Science Applications; Drug Discovery; Modeling and Simulation"
816;21100850730;npj Vaccines;journal;20590105;;-;30;16;0;687;0;0;0;42.94;United Kingdom;Western Europe;Nature Publishing Group;2016-2021;"Immunology; Infectious Diseases; Pharmacology; Pharmacology (medical)"
817;21100788744;OpenNano;journal;23529520;;-;14;4;0;120;0;0;0;30;United States;Northern America;Elsevier Inc.;2016-2019;"Biotechnology; Internal Medicine; Pharmaceutical Science; Pharmacology (medical)"
818;21100854648;Pharmaceutical Crops;journal;22102906;;-;1;1;1;24;0;1;0;24;Netherlands;Western Europe;Bentham Science Publishers B.V.;2014, 2016;"Pharmaceutical Science; Plant Science"
819;21101055117;Recent Advances in Anti-Infective Drug Discovery;journal;27724352, 27724344;;-;33;11;76;1147;142;63;1.23;104.27;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Drug Discovery; Infectious Diseases; Pharmacology (medical)"
820;21100977423;RSC Medicinal Chemistry;journal;26328682;;-;62;246;689;12753;1854;677;2.66;51.84;United Kingdom;Western Europe;Royal Society of Chemistry;2020-2021;"Biochemistry; Drug Discovery; Molecular Medicine; Organic Chemistry; Pharmaceutical Science; Pharmacology"
821;21100830708;Toxics;journal;23056304;;-;32;28;60;1908;112;58;1.96;68.14;Switzerland;Western Europe;MDPI AG;2013-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
